{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:26:30Z","timestamp":1789802790058,"version":"4.0.1"},"reference-count":432,"publisher":"Bentham Science Publishers Ltd.","issue":"9","funder":[{"DOI":"10.13039\/501100001412","name":"CSIR- Central Drug Research Institute Lucknow India communication","doi-asserted-by":"publisher","award":["9801"],"award-info":[{"award-number":["9801"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2019,7,9]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Bioavailability, one of the prime pharmacokinetic properties of a drug, is defined as the\nfraction of an administered dose of unchanged drug that reaches the systemic circulation and is used to describe\nthe systemic availability of a drug. Bioavailability assessment is imperative in order to demonstrate whether the\ndrug attains the desirable systemic exposure for effective therapy. In recent years, bioavailability has become\nthe subject of importance in drug discovery and development studies.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A systematic literature review in the field of bioavailability and the approaches towards its enhancement\nhave been comprehensively done, purely focusing upon recent papers. The data mining was performed\nusing databases like PubMed, Science Direct and general Google searches and the collected data was exhaustively\nstudied and summarized in a generalized manner.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The main prospect of this review was to generate a comprehensive one-stop summary of the numerous\navailable approaches and their pharmaceutical applications in improving the stability concerns, physicochemical\nand mechanical properties of the poorly water-soluble drugs which directly or indirectly augment their bioavailability.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The use of novel methods, including but not limited to, nano-based formulations, bio-enhancers,\nsolid dispersions, lipid-and polymer-based formulations which provide a wide range of applications not only\nincreases the solubility and permeability of the poorly bioavailable drugs but also improves their stability, and\ntargeting efficacy. Although, these methods have drastically changed the pharmaceutical industry demand for the\nnewer potential methods with better outcomes in the field of pharmaceutical science to formulate various dosage\nforms with adequate systemic availability and improved patient compliance, further research is required.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612825666190130110653","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T06:06:29Z","timestamp":1549001189000},"page":"987-1020","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Bioavailability Enhancement of Poorly Soluble Drugs: The Holy Grail in Pharma Industry"],"prefix":"10.2174","volume":"25","author":[{"given":"Mamunur","family":"Rashid","sequence":"first","affiliation":[{"name":"Pharmaceutics and Pharmacokinetics Division, CSIR-CDRI, Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Yaseen","family":"Malik","sequence":"additional","affiliation":[{"name":"Pharmaceutics and Pharmacokinetics Division, CSIR-CDRI, Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep K.","family":"Singh","sequence":"additional","affiliation":[{"name":"Pharmaceutics and Pharmacokinetics Division, CSIR-CDRI, Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Chaturvedi","sequence":"additional","affiliation":[{"name":"Pharmaceutics and Pharmacokinetics Division, CSIR-CDRI, Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaur R","family":"Gayen","sequence":"additional","affiliation":[{"name":"Pharmaceutics and Pharmacokinetics Division, CSIR-CDRI, Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Wahajuddin","sequence":"additional","affiliation":[{"name":"Pharmaceutics and Pharmacokinetics Division, CSIR-CDRI, Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF01060040","volume":"1","author":"Smolen V.F.","year":"1973","unstructured":"Smolen VF, Weigand WA. J Pharmacokinet Biopharm, Drug bioavailability and pharmacokinetic analysis from pharmacological data.,, 1973, 1,, 329-336,[http:\/\/dx.doi.org\/10.1007\/BF01060040].","journal-title":"J Pharmacokinet Biopharm"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejps.2006.06.004","volume":"29","author":"Masaoka Y.","year":"2006","unstructured":"Masaoka Y, Tanaka Y, Kataoka M, Sakuma S, Yamashita S. Eur J Pharm Sci, Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract.,, 2006, 29,, 240-250,[http:\/\/dx.doi.org\/10.1016\/j.ejps.2006.06.004]. [PMID: 16876987].","journal-title":"Eur J Pharm Sci"},{"key":"ref=3","year":"2001","unstructured":". Eur J Pharm Sci,  Health UDo, Services H. Bioanalytical Method Validation, Guidance\nfor Industry. ,, 2001, 29,, 240-, http:\/\/www.fda gov\/cder\/guidance\/4252fnl htm."},{"key":"ref=4","first-page":"61221","volume":"68","author":"Food S.","year":"2003","unstructured":"Food S. Fed Regist, Drug Administration FDA guidance (152): Guidance for industry: evaluating the safety of antimicrobial new animal drugs with regard to their microbiological effects on bacteria of human health concern.,, 2003, 68,, 61221-,","journal-title":"Fed Regist"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1011544501243","volume":"28","author":"Chiou W.L.","year":"2001","unstructured":"Chiou WL. J Pharmacokinet Pharmacodyn, The rate and extent of oral bioavailability  the rate and extent of oral absorption: clarification and recommendation of terminology.,, 2001, 28,, 3-6,[http:\/\/dx.doi.org\/10.1023\/A:1011544501243]. [PMID: 11253613].","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1067\/mcp.2000.110774","volume":"68","author":"Bailey D.G.","year":"2000","unstructured":"Bailey DG, Dresser GK, Kreeft JH, Munoz C, Freeman DJ, Bend JR. Clin Pharmacol Ther, Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients.,, 2000, 68,, 468-477,[http:\/\/dx.doi.org\/10.1067\/mcp.2000.110774]. [PMID: 11103749].","journal-title":"Clin Pharmacol Ther"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0928-0987(00)00153-6","volume":"12","author":"Schellens J.H.M.","year":"2000","unstructured":"Schellens JHM, Malingr\u00e9 MM, Kruijtzer CM. Eur J Pharm Sci, Modulation of oral bioavailability of anticancer drugs: from mouse to man.,, 2000, 12,, 103-110,[http:\/\/dx.doi.org\/10.1016\/S0928-0987(00)00153-6]. [PMID: 11102737].","journal-title":"Eur J Pharm Sci"},{"key":"ref=8","doi-asserted-by":"crossref","DOI":"10.1201\/b15445","author":"Dressman J.B.","year":"2000","unstructured":"Dressman JB, Lennernas H. Oral drug absorption: Prediction and assessment, ,, 2000, 12,, 103-,[http:\/\/dx.doi.org\/10.1201\/b15445]","journal-title":"Oral drug absorption: Prediction and assessment"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0169-409X(00)00130-7","volume":"46","year":"2001","unstructured":". Adv Drug Deliv Rev,  H\u00c3trter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract.,, 2001, 46,, 75-87,","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00487-5","volume":"25","author":"Dressman J.B.","year":"1997","unstructured":"Dressman JB. Adv Drug Deliv Rev, Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract.,, 1997, 25,, 3-14,[http:\/\/dx.doi.org\/10.1016\/S0169-409X(96)00487-5]. [PMID: 10837528].","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","volume":"22","author":"Wu C-Y.","year":"2005","unstructured":"Wu C-Y, Benet LZ. Pharm Res, Predicting drug disposition  application of BCS: transport\/absorption\/ elimination interplay and development of a biopharmaceutics drug disposition classification system.,, 2005, 22,, 11-23,[http:\/\/dx.doi.org\/10.1007\/s11095-004-9004-4]. [PMID: 15771225].","journal-title":"Pharm Res"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.23359","volume":"102","author":"Benet L.Z.","year":"2013","unstructured":"Benet LZ. J Pharm Sci, The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development.,, 2013, 102,, 34-42,[http:\/\/dx.doi.org\/10.1002\/jps.23359]. [PMID: 23147500].","journal-title":"J Pharm Sci"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1007\/s11095-011-0438-1","volume":"28","author":"Chen M-L.","year":"2011","unstructured":"Chen M-L, Amidon GL, Benet LZ, Lennernas H, Yu LX. Pharm Res, The BCS, BDDCS, and regulatory guidances.,, 2011, 28,, 1774-1778,[http:\/\/dx.doi.org\/10.1007\/s11095-011-0438-1]. [PMID: 21491148].","journal-title":"Pharm Res"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1021\/mp2004302","volume":"9","author":"Broccatelli F.","year":"2012","unstructured":"Broccatelli F, Cruciani G, Benet LZ, Oprea TI. Mol Pharm, BDDCS class prediction for new molecular entities.,, 2012, 9,, 570-580,[http:\/\/dx.doi.org\/10.1021\/mp2004302]. [PMID: 22224483].","journal-title":"Mol Pharm"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1021\/mp4007858","volume":"11","author":"Larregieu C.A.","year":"2014","unstructured":"Larregieu CA, Benet LZ. Mol Pharm, Distinguishing between the permeability relationships with absorption and metabolism to improve BCS and BDDCS predictions in early drug discovery.,, 2014, 11,, 1335-1344,[http:\/\/dx.doi.org\/10.1021\/mp4007858]. [PMID: 24628254].","journal-title":"Mol Pharm"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.addr.2011.12.008","volume":"64","author":"Broccatelli F.","year":"2012","unstructured":"Broccatelli F, Larregieu CA, Cruciani G, Oprea TI, Benet LZ. Adv Drug Deliv Rev, Improving the prediction of the brain disposition for orally administered drugs using BDDCS.,, 2012, 64,, 95-109,[http:\/\/dx.doi.org\/10.1016\/j.addr.2011.12.008]. [PMID: 22261306].","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1208\/s12248-011-9290-9","volume":"13","author":"Benet L.Z.","year":"2011","unstructured":"Benet LZ, Broccatelli F, Oprea TI. AAPS J, BDDCS applied to over 900 drugs.,, 2011, 13,, 519-547,[http:\/\/dx.doi.org\/10.1208\/s12248-011-9290-9]. [PMID: 21818695].","journal-title":"AAPS J"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0300-483X(95)03206-U","volume":"105","author":"Calabrese E.J.","year":"1995","unstructured":"Calabrese EJ. Toxicology, Toxicological consequences of multiple chemical interactions: a primer.,, 1995, 105,, 121-135,[http:\/\/dx.doi.org\/10.1016\/0300-483X(95)03206-U]. [PMID: 8571351].","journal-title":"Toxicology"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/03639049809085635","volume":"24","author":"Alsaidan S.M.","year":"1998","unstructured":"Alsaidan SM, Alsughayer AA, Eshra AG. Drug Dev Ind Pharm, Improved dissolution rate of indomethacin by adsorbents.,, 1998, 24,, 389-394,[http:\/\/dx.doi.org\/10.3109\/03639049809085635]. [PMID: 9876600].","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1023\/A:1016473601633","volume":"19","author":"Yu L.X.","year":"2002","unstructured":"Yu LX, Amidon GL, Polli JE. Pharm Res, Biopharmaceutics classification system: the scientific basis for biowaiver extensions.,, 2002, 19,, 921-925,[http:\/\/dx.doi.org\/10.1023\/A:1016473601633]. [PMID: 12180542].","journal-title":"Pharm Res"},{"key":"ref=21","author":"Polli JE","year":"2002","unstructured":"Polli JE, Yu LX, Mehta MU, Amidon GL, Zhao H, Lesko LJ. Pharm Res, Biopharmaceutics Classification System: The Scientific Basis for\nBiowaiver Extensions.,, 2002, 19,, 921-,"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0378-5173(00)00344-6","volume":"201","author":"Panchagnula R.","year":"2000","unstructured":"Panchagnula R, Thomas NS. Int J Pharm, Biopharmaceutics and pharmacokinetics in drug research.,, 2000, 201,, 131-150,[http:\/\/dx.doi.org\/10.1016\/S0378-5173(00)00344-6]. [PMID: 10878321].","journal-title":"Int J Pharm"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1124\/dmd.31.12.1507","volume":"31","author":"Pang K.S.","year":"2003","unstructured":"Pang KS. Drug Metab Dispos, Modeling of intestinal drug absorption: roles of transporters and metabolic enzymes (for the Gillette Review Series).,, 2003, 31,, 1507-1519,[http:\/\/dx.doi.org\/10.1124\/dmd.31.12.1507]. [PMID: 14625347].","journal-title":"Drug Metab Dispos"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/117739280700200003","volume":"2","author":"Hamman J.H.","year":"2007","unstructured":"Hamman JH, Demana PH, Olivier EI. Drug Target Insights, Targeting receptors, transporters and site of absorption to improve oral drug delivery.,, 2007, 2,, 71-81,[http:\/\/dx.doi.org\/10.1177\/117739280700200003]. [PMID: 21901064].","journal-title":"Drug Target Insights"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-199936030-00004","volume":"36","author":"Fleisher D.","year":"1999","unstructured":"Fleisher D, Li C, Zhou Y, Pao L-H, Karim A. Clin Pharmacokinet, Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.,, 1999, 36,, 233-254,[http:\/\/dx.doi.org\/10.2165\/00003088-199936030-00004]. [PMID: 10223170].","journal-title":"Clin Pharmacokinet"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/03602532.2016.1157600","volume":"48","author":"Malik M.Y.","year":"2016","unstructured":"Malik MY, Jaiswal S, Sharma A, Shukla M, Lal J. Drug Metab Rev, Role of enterohepatic recirculation in drug disposition: cooperation and complications.,, 2016, 48,, 281-327,[http:\/\/dx.doi.org\/10.3109\/03602532.2016.1157600]. [PMID: 26987379].","journal-title":"Drug Metab Rev"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.addr.2012.09.027","volume":"64","author":"Schinkel A.H.","year":"2012","unstructured":"Schinkel AH, Jonker JW. Adv Drug Deliv Rev, Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.,, 2012, 64,, 138-153,[http:\/\/dx.doi.org\/10.1016\/j.addr.2012.09.027]. [PMID: 12535572].","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2015.10.010","volume":"370","author":"Chen Z.","year":"2016","unstructured":"Chen Z, Shi T, Zhang L. Cancer Lett, Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.,, 2016, 370,, 153-164,[http:\/\/dx.doi.org\/10.1016\/j.canlet.2015.10.010]. [PMID: 26499806].","journal-title":"Cancer Lett"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0169-409X(02)00175-8","volume":"55","author":"Dantzig A.H.","year":"2003","unstructured":"Dantzig AH, de Alwis DP, Burgess M. Adv Drug Deliv Rev, Considerations in the design and development of transport inhibitors as adjuncts to drug therapy.,, 2003, 55,, 133-150,[http:\/\/dx.doi.org\/10.1016\/S0169-409X(02)00175-8]. [PMID: 12535578].","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=30","author":"Broder S","year":"2001","unstructured":"Broder S, Duchin KL, Selim S. Adv Drug Deliv Rev, . Method, compositions and kits for\nincreasing the oral bioavailability of pharmaceutical agents.\nUS20030069301A1,, 2001, 55,, 133-,"},{"key":"ref=31","author":"Humphrey MJ","year":"2003","unstructured":"Humphrey MJ. Adv Drug Deliv Rev,  Compositions having improved bioavailability.\nUS6579898B2, ,, 2003, 55,, 133-,"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/js960085v","volume":"86","author":"Charman W.N.","year":"1997","unstructured":"Charman WN, Porter CJH, Mithani S, Dressman JB. J Pharm Sci, Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.,, 1997, 86,, 269-282,[http:\/\/dx.doi.org\/10.1021\/js960085v]. [PMID: 9050793].","journal-title":"J Pharm Sci"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00007691-200002000-00028","volume":"22","author":"Evans A.M.","year":"2000","unstructured":"Evans AM. Ther Drug Monit, Influence of dietary components on the gastrointestinal metabolism and transport of drugs.,, 2000, 22,, 131-136,[http:\/\/dx.doi.org\/10.1097\/00007691-200002000-00028]. [PMID: 10688276].","journal-title":"Ther Drug Monit"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-2362.33.s2.2.x","volume":"33","author":"Dresser G.K.","year":"2003","unstructured":"Dresser GK, Bailey DG. Eur J Clin Invest, The effects of fruit juices on drug disposition: a new model for drug interactions.,, 2003, 33,, 10-16,[http:\/\/dx.doi.org\/10.1046\/j.1365-2362.33.s2.2.x]. [PMID: 14641551].","journal-title":"Eur J Clin Invest"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.3390\/nu5093367","volume":"5","author":"Thilakarathna S.H.","year":"2013","unstructured":"Thilakarathna SH, Rupasinghe HP. Nutrients, Flavonoid bioavailability and attempts for bioavailability enhancement.,, 2013, 5,, 3367-3387,[http:\/\/dx.doi.org\/10.3390\/nu5093367]. [PMID: 23989753].","journal-title":"Nutrients"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ajcn\/79.5.727","volume":"79","author":"Manach C.","year":"2004","unstructured":"Manach C, Scalbert A, Morand C, R\u00e9m\u00e9sy C, Jim\u00e9nez L. Am J Clin Nutr, Polyphenols: food sources and bioavailability.,, 2004, 79,, 727-747,[http:\/\/dx.doi.org\/10.1093\/ajcn\/79.5.727]. [PMID: 15113710].","journal-title":"Am J Clin Nutr"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1271\/bbb.100593","volume":"75","author":"Monobe M.","year":"2011","unstructured":"Monobe M, Ema K, Tokuda Y, Maeda-Yamamoto M. Biosci Biotechnol Biochem, Increased plasma concentration of epigallocatechin in mice after orally administering a green tea (Camellia sinensis L.) extract supplemented by steamed rice.,, 2011, 75,, 152-154,[http:\/\/dx.doi.org\/10.1271\/bbb.100593]. [PMID: 21228465].","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jff.2015.05.006","volume":"17","author":"Jilani H.","year":"2015","unstructured":"Jilani H, Cilla A, Barber\u00e1 R, Hamdi M. J Funct Foods, Biosorption of green and black tea polyphenols into  improves their bioaccessibility.,, 2015, 17,, 11-21,[http:\/\/dx.doi.org\/10.1016\/j.jff.2015.05.006].","journal-title":"J Funct Foods"},{"key":"ref=39","author":"Moruisi KG","year":"2008","unstructured":"Moruisi KG. J Funct Foods,  The Effect of a Fatty Acid-based Carrier on the\nBioavailability of Epigallocatechin Gallate: Citeseer.,, 2008, 17,, 11-,"},{"key":"ref=40","first-page":"33","volume":"4","author":"Lee C.","year":"2006","unstructured":"Lee C, Cheng H, Sim S. Curr Top Nutraceutical Res, Bioavailability of dietary flavonoids and carotenoids.,, 2006, 4,, 33-,","journal-title":"Curr Top Nutraceutical Res"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1080\/10408398.2014.994700","volume":"57","author":"Singh B.N.","year":"2017","unstructured":"Singh BN, Rawat AK, Bhagat RM, Singh BR. Crit Rev Food Sci Nutr, Black tea: Phytochemicals, cancer chemoprevention, and clinical studies.,, 2017, 57,, 1394-1410,[http:\/\/dx.doi.org\/10.1080\/10408398.2014.994700]. [PMID: 26561007].","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.1021\/acs.jafc.7b02128","volume":"65","author":"Xiao J.","year":"2017","unstructured":"Xiao J, Cao Y, Huang Q. J Agric Food Chem, Edible nanoencapsulation vehicles for oral delivery of phytochemicals: a perspective paper.,, 2017, 65,, 6727-6735,[http:\/\/dx.doi.org\/10.1021\/acs.jafc.7b02128]. [PMID: 28737908].","journal-title":"J Agric Food Chem"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1111\/j.1750-3841.2010.01957.x","volume":"76","author":"Palafox-Carlos H.","year":"2011","unstructured":"Palafox-Carlos H, Ayala-Zavala JF, Gonz\u00e1lez-Aguilar GA. J Food Sci, The role of dietary fiber in the bioaccessibility and bioavailability of fruit and vegetable antioxidants.,, 2011, 76,, R6-R15,[http:\/\/dx.doi.org\/10.1111\/j.1750-3841.2010.01957.x]. [PMID: 21535705].","journal-title":"J Food Sci"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1111\/j.1750-3841.2007.00274.x","volume":"72","author":"Parada J.","year":"2007","unstructured":"Parada J, Aguilera JM. J Food Sci, Food microstructure affects the bioavailability of several nutrients.,, 2007, 72,, R21-R32,[http:\/\/dx.doi.org\/10.1111\/j.1750-3841.2007.00274.x]. [PMID: 17995848].","journal-title":"J Food Sci"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/ajcn\/62.6.1276","volume":"62","author":"Hollman P.C.","year":"1995","unstructured":"Hollman PC, de Vries JH, van Leeuwen SD, Mengelers MJ, Katan MB. Am J Clin Nutr, Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers.,, 1995, 62,, 1276-1282,[http:\/\/dx.doi.org\/10.1093\/ajcn\/62.6.1276]. [PMID: 7491892].","journal-title":"Am J Clin Nutr"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12349-009-0051-6","volume":"3","author":"Alvarez-Suarez J.M.","year":"2010","unstructured":"Alvarez-Suarez JM, Tulipani S, Romandini S, Bertoli E, Battino M. Med J Nutrition Metab, Contribution of honey in nutrition and human health: a review.,, 2010, 3,, 15-23,[http:\/\/dx.doi.org\/10.1007\/s12349-009-0051-6].","journal-title":"Med J Nutrition Metab"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(98)01101-6","volume":"436","author":"Day A.J.","year":"1998","unstructured":"Day AJ, DuPont MS, Ridley S. FEBS Lett, Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver \u03b2-glucosidase activity.,, 1998, 436,, 71-75,[http:\/\/dx.doi.org\/10.1016\/S0014-5793(98)01101-6]. [PMID: 9771896].","journal-title":"FEBS Lett"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ejpb.2012.06.016","volume":"82","author":"Zhang M.","year":"2012","unstructured":"Zhang M, Li H, Lang B. Eur J Pharm Biopharm, Formulation and delivery of improved amorphous fenofibrate solid dispersions prepared by thin film freezing.,, 2012, 82,, 534-544,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2012.06.016]. [PMID: 22974985].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0378-5173(95)04114-1","volume":"126","author":"Betageri G.V.","year":"1995","unstructured":"Betageri GV, Makarla KR. Int J Pharm, Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques.,, 1995, 126,, 155-160,[http:\/\/dx.doi.org\/10.1016\/0378-5173(95)04114-1].","journal-title":"Int J Pharm"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-5173(02)00072-8","volume":"243","author":"Sarkari M.","year":"2002","unstructured":"Sarkari M, Brown J, Chen X, Swinnea S, Williams RO, Johnston KP. Int J Pharm, Enhanced drug dissolution using evaporative precipitation into aqueous solution.,, 2002, 243,, 17-31,[http:\/\/dx.doi.org\/10.1016\/S0378-5173(02)00072-8]. [PMID: 12176292].","journal-title":"Int J Pharm"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1248\/cpb.59.438","volume":"59","author":"Boghra R.J.","year":"2011","unstructured":"Boghra RJ, Kothawade PC, Belgamwar VS, Nerkar PP, Tekade AR, Surana SJ. Chem Pharm Bull (Tokyo), Solubility, dissolution rate and bioavailability enhancement of irbesartan by solid dispersion technique.,, 2011, 59,, 438-441,[http:\/\/dx.doi.org\/10.1248\/cpb.59.438]. [PMID: 21467670].","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ejpb.2012.07.012","volume":"82","author":"Zhao M.","year":"2012","unstructured":"Zhao M, Barker SA, Belton PS, McGregor C, Craig DQM. Eur J Pharm Biopharm, Development of fully amorphous dispersions of a low T(g) drug  co-spray drying with hydrophilic polymers.,, 2012, 82,, 572-579,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2012.07.012]. [PMID: 22922419].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/jps.2600561006","volume":"56","author":"Aguiar A.J.","year":"1967","unstructured":"Aguiar AJ, Zelmer JE, Kinkel AW. J Pharm Sci, Deaggregation behavior of a relatively insoluble substituted benzoic acid and its sodium salt.,, 1967, 56,, 1243-1252,[http:\/\/dx.doi.org\/10.1002\/jps.2600561006]. [PMID: 6059441].","journal-title":"J Pharm Sci"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/cbdd.12224","volume":"82","author":"Karaman R.","year":"2013","unstructured":"Karaman R. Chem Biol Drug Des, Prodrugs design based on inter- and intramolecular chemical processes.,, 2013, 82,, 643-668,[http:\/\/dx.doi.org\/10.1111\/cbdd.12224]. [PMID: 23998799].","journal-title":"Chem Biol Drug Des"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/jps.2600600902","volume":"60","author":"Chiou W.L.","year":"1971","unstructured":"Chiou WL, Riegelman S. J Pharm Sci, Pharmaceutical applications of solid dispersion systems.,, 1971, 60,, 1281-1302,[http:\/\/dx.doi.org\/10.1002\/jps.2600600902]. [PMID: 4935981].","journal-title":"J Pharm Sci"},{"key":"ref=56","author":"Cha Y","year":"1997","unstructured":"Cha Y, Choi YK, Pai CM. J Pharm Sci, . Preparation of peptide containing biodegradable\nmicrospheres by melt process. WO1997015389A1, ,, 1997, 60,, 1281-,"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.addr.2007.05.011","volume":"59","author":"Blagden N.","year":"2007","unstructured":"Blagden N, de Matas M, Gavan PT, York P. Adv Drug Deliv Rev, Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.,, 2007, 59,, 617-630,[http:\/\/dx.doi.org\/10.1016\/j.addr.2007.05.011]. [PMID: 17597252].","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=58","first-page":"7036","volume":"5","author":"Kumar R.S.","year":"2016","unstructured":"Kumar RS, Yagnesh TNS. Indo Am J Pharm Res, Solid dispersions: An approach to enhance solubility of poorly soluble drugs.,, 2016, 5,, 7036-7056,","journal-title":"Indo Am J Pharm Res"},{"key":"ref=59","first-page":"1338","volume":"1","author":"Tiwari R.","year":"2009","unstructured":"Tiwari R, Tiwari G, Srivastava B, Rai AK. Int J Pharm Tech Res, Solid dispersions: an overview to modify bioavailability of poorly water soluble drugs.,, 2009, 1,, 1338-1349,","journal-title":"Int J Pharm Tech Res"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12272-013-0012-y","volume":"36","author":"Tran T.H.","year":"2013","unstructured":"Tran TH, Poudel BK, Marasini N. Arch Pharm Res, Development of raloxifene-solid dispersion with improved oral bioavailability  spray-drying technique.,, 2013, 36,, 86-93,[http:\/\/dx.doi.org\/10.1007\/s12272-013-0012-y]. [PMID: 23325488].","journal-title":"Arch Pharm Res"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.drudis.2007.09.005","volume":"12","author":"Vasconcelos T.","year":"2007","unstructured":"Vasconcelos T, Sarmento B, Costa P. Drug Discov Today, Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.,, 2007, 12,, 1068-1075,[http:\/\/dx.doi.org\/10.1016\/j.drudis.2007.09.005]. [PMID: 18061887].","journal-title":"Drug Discov Today"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ajps.2014.05.005","volume":"9","author":"Khadka P.","year":"2014","unstructured":"Khadka P, Ro J, Kim H. Asian J Pharma Sci, Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability.,, 2014, 9,, 304-316,","journal-title":"Asian J Pharma Sci"},{"key":"ref=63","first-page":"63","volume":"2","author":"Prakash S.J.","year":"2014","unstructured":"Prakash SJ, Santhiagu A, Jasemine S. J Pharm Biomed Sci, Preparation, characterization and  evaluation of novel gellan gum-raloxifene HCl nanoparticles.,, 2014, 2,, 63-71,","journal-title":"J Pharm Biomed Sci"},{"key":"ref=64","first-page":"127","volume":"8","year":"2016","unstructured":". Int J Pharm Pharm Sci, GHANEM SF.Preparation and evaluation of rapidly dissolving tablets of raloxifene hydrochloride by ternary system formation.,, 2016, 8,, 127-136,","journal-title":"Int J Pharm Pharm Sci"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0939-6411(00)00076-X","volume":"50","author":"Leuner C.","year":"2000","unstructured":"Leuner C, Dressman J. Eur J Pharm Biopharm, Improving drug solubility for oral delivery using solid dispersions.,, 2000, 50,, 47-60,[http:\/\/dx.doi.org\/10.1016\/S0939-6411(00)00076-X]. [PMID: 10840192].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.addr.2003.10.009","volume":"56","author":"Zhang G.G.","year":"2004","unstructured":"Zhang GG, Law D, Schmitt EA, Qiu Y. Adv Drug Deliv Rev, Phase transformation considerations during process development and manufacture of solid oral dosage forms.,, 2004, 56,, 371-390,[http:\/\/dx.doi.org\/10.1016\/j.addr.2003.10.009]. [PMID: 14962587].","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i23.40","volume":"20","author":"Sethia S.","year":"2003","unstructured":"Sethia S, Squillante E. Crit Rev Ther Drug Carrier Syst, Solid dispersions: revival with greater possibilities and applications in oral drug delivery.,, 2003, 20,, 215-247,[http:\/\/dx.doi.org\/10.1615\/CritRevTherDrugCarrierSyst.v20.i23.40].","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1517\/17425247.2011.606808","volume":"8","author":"Singh A.","year":"2011","unstructured":"Singh A, Worku ZA, Van den Mooter G. Expert Opin Drug Deliv, Oral formulation strategies to improve solubility of poorly water-soluble drugs.,, 2011, 8,, 1361-1378,[http:\/\/dx.doi.org\/10.1517\/17425247.2011.606808]. [PMID: 21810062].","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","volume":"59","author":"Brewster M.E.","year":"2007","unstructured":"Brewster ME, Loftsson T. Adv Drug Deliv Rev, Cyclodextrins as pharmaceutical solubilizers.,, 2007, 59,, 645-666,[http:\/\/dx.doi.org\/10.1016\/j.addr.2007.05.012]. [PMID: 17601630].","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2007.07.018","volume":"123","author":"Carrier R.L.","year":"2007","unstructured":"Carrier RL, Miller LA, Ahmed I. J Control Release, The utility of cyclodextrins for enhancing oral bioavailability.,, 2007, 123,, 78-99,[http:\/\/dx.doi.org\/10.1016\/j.jconrel.2007.07.018]. [PMID: 17888540].","journal-title":"J Control Release"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3797\/scipharm.0808-05","volume":"76","author":"Rasheed A.","year":"2008","unstructured":"Rasheed A. Sci Pharm, VVNS SS. Cyclodextrins as drug carrier molecule: a review.,, 2008, 76,, 567-598,[http:\/\/dx.doi.org\/10.3797\/scipharm.0808-05].","journal-title":"Sci Pharm"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0378-5173(98)00382-2","volume":"179","author":"Becket G.","year":"1999","unstructured":"Becket G, Schep LJ, Tan MY. Int J Pharm, Improvement of the  dissolution of praziquantel by complexation with \u03b1-, \u03b2- and \u03b3-cyclodextrins.,, 1999, 179,, 65-71,[http:\/\/dx.doi.org\/10.1016\/S0378-5173(98)00382-2]. [PMID: 10053203].","journal-title":"Int J Pharm"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejpb.2003.10.020","volume":"57","author":"Rawat S.","year":"2004","unstructured":"Rawat S, Jain SK. Eur J Pharm Biopharm, Solubility enhancement of celecoxib using \u03b2-cyclodextrin inclusion complexes.,, 2004, 57,, 263-267,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2003.10.020]. [PMID: 15018983].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3109\/10717544.2013.853213","volume":"21","author":"Nair A.B.","year":"2014","unstructured":"Nair AB, Attimarad M, Al-Dhubiab BE, Wadhwa J, Harsha S, Ahmed M. Drug Deliv, Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-\u03b2-cyclodextrin.,, 2014, 21,, 540-547,[http:\/\/dx.doi.org\/10.3109\/10717544.2013.853213]. [PMID: 24215288].","journal-title":"Drug Deliv"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3109\/03639045.2012.694588","volume":"39","author":"Wu J.","year":"2013","unstructured":"Wu J, Shen Q, Fang L. Drug Dev Ind Pharm, Sulfobutylether-\u03b2-cyclodextrin\/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel.,, 2013, 39,, 1010-1019,[http:\/\/dx.doi.org\/10.3109\/03639045.2012.694588]. [PMID: 22681515].","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4103\/0250-474X.57283","volume":"71","author":"Yadav A.V.","year":"2009","unstructured":"Yadav AV, Shete AS, Dabke AP, Kulkarni PV, Sakhare SS. Indian J Pharm Sci, Co-crystals: a novel approach to modify physicochemical properties of active pharmaceutical ingredients.,, 2009, 71,, 359-370,[http:\/\/dx.doi.org\/10.4103\/0250-474X.57283]. [PMID: 20502540].","journal-title":"Indian J Pharm Sci"},{"key":"ref=77","first-page":"50","author":"Sekhon B.S.","year":"2009","unstructured":"Sekhon BS. Pharmaceutical co-crystals-a review, ,, 2009, 71,, 50-,","journal-title":"Pharmaceutical co-crystals-a review"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1021\/cg4000439","volume":"13","author":"Kelley S.P.","year":"2013","unstructured":"Kelley SP, Narita A, Holbrey JD, Green KD, Reichert WM, Rogers RD. Cryst Growth Des, Understanding the effects of ionicity in salts, solvates, co-crystals, ionic co-crystals, and ionic liquids, rather than nomenclature, is critical to understanding their behavior.,, 2013, 13,, 965-975,[http:\/\/dx.doi.org\/10.1021\/cg4000439].","journal-title":"Cryst Growth Des"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijpharm.2012.11.028","volume":"453","author":"Elder D.P.","year":"2013","unstructured":"Elder DP, Holm R, Diego HL. Int J Pharm, Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.,, 2013, 453,, 88-100,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2012.11.028]. [PMID: 23182973].","journal-title":"Int J Pharm"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijpharm.2006.04.018","volume":"320","author":"Trask A.V.","year":"2006","unstructured":"Trask AV, Motherwell WD, Jones W. Int J Pharm, Physical stability enhancement of theophylline  cocrystallization.,, 2006, 320,, 114-123,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2006.04.018]. [PMID: 16769188].","journal-title":"Int J Pharm"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.tips.2012.12.003","volume":"34","author":"Steed J.W.","year":"2013","unstructured":"Steed JW. Trends Pharmacol Sci, The role of co-crystals in pharmaceutical design.,, 2013, 34,, 185-193,[http:\/\/dx.doi.org\/10.1016\/j.tips.2012.12.003]. [PMID: 23347591].","journal-title":"Trends Pharmacol Sci"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1039\/b503718b","author":"Aaker\u00f6y C.B.","year":"2005","unstructured":"Aaker\u00f6y CB, Desper J, Urbina JF. Chem Commun (Camb), Supramolecular reagents: versatile tools for non-covalent synthesis.,, 2005, 34,, 2820-2822,[http:\/\/dx.doi.org\/10.1039\/b503718b]. [PMID: 15928769].","journal-title":"Chem Commun (Camb)"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejps.2007.05.110","volume":"31","author":"Stegemann S.","year":"2007","unstructured":"Stegemann S, Leveiller F, Franchi D, de Jong H, Lind\u00e9n H. Eur J Pharm Sci, When poor solubility becomes an issue: from early stage to proof of concept.,, 2007, 31,, 249-261,[http:\/\/dx.doi.org\/10.1016\/j.ejps.2007.05.110]. [PMID: 17616376].","journal-title":"Eur J Pharm Sci"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jps.20578","volume":"95","author":"Vishweshwar P.","year":"2006","unstructured":"Vishweshwar P, McMahon JA, Bis JA, Zaworotko MJ. J Pharm Sci, Pharmaceutical co-crystals.,, 2006, 95,, 499-516,[http:\/\/dx.doi.org\/10.1002\/jps.20578]. [PMID: 16444755].","journal-title":"J Pharm Sci"},{"key":"ref=85","first-page":"33","volume":"4","author":"Hetal T.","year":"2010","unstructured":"Hetal T, Bindesh P, Sneha T. Health, A review on techniques for oral bioavailability enhancement of drugs.,, 2010, 4,, 33-,","journal-title":"Health"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1021\/cg800035w","volume":"8","author":"Berry D.J.","year":"2008","unstructured":"Berry DJ, Seaton CC, Clegg W. Cryst Growth Des, Applying hot-stage microscopy to co-crystal screening: a study of nicotinamide with seven active pharmaceutical ingredients.,, 2008, 8,, 1697-1712,[http:\/\/dx.doi.org\/10.1021\/cg800035w].","journal-title":"Cryst Growth Des"},{"key":"ref=87","first-page":"84","volume":"2","author":"Ain S.","year":"2009","unstructured":"Ain S, Ain Q, Parveen S. Pharm Res, An overview on various approaches used for solubilization of poorly soluble drugs.,, 2009, 2,, 84-104,","journal-title":"Pharm Res"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ejpb.2006.11.025","volume":"66","author":"Bouquet W.","year":"2007","unstructured":"Bouquet W, Ceelen W, Fritzinger B. Eur J Pharm Biopharm, Paclitaxel\/\u03b2-cyclodextrin complexes for hyperthermic peritoneal perfusion - formulation and stability.,, 2007, 66,, 391-397,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2006.11.025]. [PMID: 17240125].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/jps.23807","volume":"103","author":"Rong W-T.","year":"2014","unstructured":"Rong W-T, Lu Y-P, Tao Q. J Pharm Sci, Hydroxypropyl-sulfobutyl-\u03b2-cyclodextrin improves the oral bioavailability of edaravone by modulating drug efflux pump of enterocytes.,, 2014, 103,, 730-742,[http:\/\/dx.doi.org\/10.1002\/jps.23807]. [PMID: 24311389].","journal-title":"J Pharm Sci"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijbiomac.2013.10.007","volume":"62","author":"Leonardi D.","year":"2013","unstructured":"Leonardi D, Bombardiere ME, Salomon CJ. Int J Biol Macromol, Effects of benznidazole:cyclodextrin complexes on the drug bioavailability upon oral administration to rats.,, 2013, 62,, 543-548,[http:\/\/dx.doi.org\/10.1016\/j.ijbiomac.2013.10.007]. [PMID: 24120966].","journal-title":"Int J Biol Macromol"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1208\/s12249-015-0363-4","volume":"17","author":"Zhang X.","year":"2016","unstructured":"Zhang X, Zhang T, Lan Y, Wu B, Shi Z. AAPS PharmSciTech, Nanosuspensions containing oridonin\/HP-\u03b2-cyclodextrin inclusion complexes for oral bioavailability enhancement via improved dissolution and permeability.,, 2016, 17,, 400-408,[http:\/\/dx.doi.org\/10.1208\/s12249-015-0363-4]. [PMID: 26187778].","journal-title":"AAPS PharmSciTech"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1208\/s12249-013-9982-9","volume":"14","author":"Balducci A.G.","year":"2013","unstructured":"Balducci AG, Magosso E, Colombo G. AAPS PharmSciTech, Agglomerated oral dosage forms of artemisinin\/\u03b2-cyclodextrin spray-dried primary microparticles showing increased dissolution rate and bioavailability.,, 2013, 14,, 911-918,[http:\/\/dx.doi.org\/10.1208\/s12249-013-9982-9]. [PMID: 23703233].","journal-title":"AAPS PharmSciTech"},{"key":"ref=93","first-page":"791","volume":"70","author":"Lu R.","year":"2015","unstructured":"Lu R, Liu S, Wang Q, Li X. Pharmazie, Enhanced bioavailability of raloxifene hydrochloride  dry suspensions prepared from drug\/HP-\u03b2-cyclodextrin inclusion complexes.,, 2015, 70,, 791-797,[PMID: 26817276].","journal-title":"Pharmazie"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3109\/03639045.2012.718785","volume":"39","author":"Bourkaib N.","year":"2013","unstructured":"Bourkaib N, Zhou J, Yao J, Fang Z, Mezghrani O. Drug Dev Ind Pharm, Combination of \u03b2-cyclodextrin inclusion complex and self-microemulsifying drug delivery system for photostability and enhanced oral bioavailability of methotrexate: novel technique.,, 2013, 39,, 918-927,[http:\/\/dx.doi.org\/10.3109\/03639045.2012.718785]. [PMID: 22998295].","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijpharm.2014.10.038","volume":"477","author":"Liu M.","year":"2014","unstructured":"Liu M, Cao W, Sun Y, He Z. Int J Pharm, Preparation, characterization and  evaluation of formulation of repaglinide with hydroxypropyl-\u03b2-cyclodextrin.,, 2014, 477,, 159-166,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2014.10.038]. [PMID: 25455768].","journal-title":"Int J Pharm"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1166\/jbn.2015.2110","volume":"11","author":"Wu J.","year":"2015","unstructured":"Wu J, Bu X, Dou L, Fang L, Shen Q. J Biomed Nanotechnol, Co-delivery of Docetaxel and Berbamine by Chitosan\/Sulfobutylether-\u03b2-Cyclodextrin nanoparticles for enhancing bioavailability and anticancer activities.,, 2015, 11,, 1847-1857,[http:\/\/dx.doi.org\/10.1166\/jbn.2015.2110]. [PMID: 26502647].","journal-title":"J Biomed Nanotechnol"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/10837450.2011.591801","volume":"18","author":"Chauhan R.","year":"2013","unstructured":"Chauhan R, Madan J, Kaushik D, Sardana S, Pandey RS, Sharma R. Pharm Dev Technol, Inclusion complex of colchicine in hydroxypropyl-\u03b2-cyclodextrin tenders better solubility and improved pharmacokinetics.,, 2013, 18,, 313-322,[http:\/\/dx.doi.org\/10.3109\/10837450.2011.591801]. [PMID: 21699389].","journal-title":"Pharm Dev Technol"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.carbpol.2014.04.006","volume":"110","author":"Yao Y.","year":"2014","unstructured":"Yao Y, Xie Y, Hong C, Li G, Shen H, Ji G. Carbohydr Polym, Development of a myricetin\/hydroxypropyl-\u03b2-cyclodextrin inclusion complex: preparation, characterization, and evaluation.,, 2014, 110,, 329-337,[http:\/\/dx.doi.org\/10.1016\/j.carbpol.2014.04.006]. [PMID: 24906763].","journal-title":"Carbohydr Polym"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3109\/03639045.2012.681382","volume":"39","author":"Kumar N.","year":"2013","unstructured":"Kumar N. Drug Dev Ind Pharm, Shishu, Bansal G, Kumar S, Jana AK. Preparation and cyclodextrin assisted dissolution rate enhancement of itraconazolium dinitrate salt.,, 2013, 39,, 342-351,[http:\/\/dx.doi.org\/10.3109\/03639045.2012.681382]. [PMID: 22553909].","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"e18033","DOI":"10.1371\/journal.pone.0018033","volume":"6","author":"Shulman M.","year":"2011","unstructured":"Shulman M, Cohen M, Soto-Gutierrez A. PLoS One, Enhancement of naringenin bioavailability by complexation with hydroxypropyl-\u03b2-cyclodextrin.,, 2011, 6,, e18033-,[http:\/\/dx.doi.org\/10.1371\/journal.pone.0018033]. [PMID: 21494673].","journal-title":"PLoS One"},{"key":"ref=101","first-page":"46","volume":"67","author":"Lv H-X.","year":"2012","unstructured":"Lv H-X, Zhang Z-H. Pharmazie, Hui-Jiang, Waddad AY, Zhou JP. Preparation, physicochemical characteristics and bioavailability studies of an atorvastatin hydroxypropyl-\u03b2-cyclodextrin complex.,, 2012, 67,, 46-53,[PMID: 22393830].","journal-title":"Pharmazie"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0023677213503823","volume":"48","author":"Grecu M.","year":"2014","unstructured":"Grecu M, N\u0103stas\u0103 V, Ilie C, Miron L, Mare\u015f M. Lab Anim, Comparative assessment of effectiveness of ketoprofen and ketoprofen\/beta-cyclodextrin complex in two experimental models of inflammation in rats.,, 2014, 48,, 20-26,[http:\/\/dx.doi.org\/10.1177\/0023677213503823]. [PMID: 24072487].","journal-title":"Lab Anim"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.carbpol.2015.08.012","volume":"134","author":"Devasari N.","year":"2015","unstructured":"Devasari N, Dora CP, Singh C. Carbohydr Polym, Inclusion complex of erlotinib with sulfobutyl ether-\u03b2-cyclodextrin: Preparation, characterization,  and  evaluation.,, 2015, 134,, 547-556,[http:\/\/dx.doi.org\/10.1016\/j.carbpol.2015.08.012]. [PMID: 26428157].","journal-title":"Carbohydr Polym"},{"key":"ref=104","first-page":"143","volume":"67","author":"Gu F.G.","year":"2012","unstructured":"Gu FG, Wang Y, Meng GD, Han HB, Wu CZ. Pharmazie, Investigation of a fenofibrate-hydroxypropyl-\u03b2-cyclodextrin system prepared by a co-grinding method.,, 2012, 67,, 143-146,[PMID: 22512084].","journal-title":"Pharmazie"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1002\/jps.24212","volume":"104","author":"Hymas R.V.","year":"2015","unstructured":"Hymas RV, Ho NF, Higuchi WI. J Pharm Sci, Capric Acid Absorption in the Presence of Hydroxypropyl-\u03b2-Cyclodextrin in the Rat Ileum using the In Situ Single-Pass Perfusion Technique.,, 2015, 104,, 2832-2844,[http:\/\/dx.doi.org\/10.1002\/jps.24212]. [PMID: 25393711].","journal-title":"J Pharm Sci"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejpb.2016.01.007","volume":"101","author":"Holm R.","year":"2016","unstructured":"Holm R, Olesen NE, Hartvig RA, J\u00f8rgensen EB, Larsen DB, Westh P. Eur J Pharm Biopharm, Effect of cyclodextrin concentration on the oral bioavailability of danazol and cinnarizine in rats.,, 2016, 101,, 9-14,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2016.01.007]. [PMID: 26776271].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.1997.tb01480.x","volume":"38","author":"Samr\u00e9n E.B.","year":"1997","unstructured":"Samr\u00e9n EB, van Duijn CM, Koch S. Epilepsia, Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy.,, 1997, 38,, 981-990,[http:\/\/dx.doi.org\/10.1111\/j.1528-1157.1997.tb01480.x]. [PMID: 9579936].","journal-title":"Epilepsia"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.drudis.2008.03.004","volume":"13","author":"Shan N.","year":"2008","unstructured":"Shan N, Zaworotko MJ. Drug Discov Today, The role of cocrystals in pharmaceutical science.,, 2008, 13,, 440-446,[http:\/\/dx.doi.org\/10.1016\/j.drudis.2008.03.004]. [PMID: 18468562].","journal-title":"Drug Discov Today"},{"key":"ref=109","author":"Zaworotko MJ","unstructured":"Zaworotko MJ, Arora KK. Polymorphism in Pharmaceutical Solids,\nSecond Edition: CRC Press;, Pharmaceutical co-crystals: A new opportunity in pharmaceutical science for a long-known but little-studied class of compounds.,, , 13,, 440-,2p 292-327.","journal-title":"Polymorphism in Pharmaceutical Solids,\nSecond Edition: CRC Press;"},{"key":"ref=110","first-page":"187","author":"Shan N.","year":"2003","unstructured":"Shan N, Zaworotko MJ. Polymorphic crystal forms and cocrystals in drug delivery (crystal engineering), ,, 2003, 13,, 187-218,","journal-title":"Polymorphic crystal forms and cocrystals in drug delivery (crystal engineering)"},{"key":"ref=111","first-page":"725","volume":"1","author":"Prasad R.V.","year":"2012","unstructured":"Prasad RV, Rakesh MG, Jyotsna RM, Mangesh ST, Anita PS, Mayur PK. Int J Pharm Chem Sci, Pharmaceutical cocrystallization: a review.,, 2012, 1,, 725-736,","journal-title":"Int J Pharm Chem Sci"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1021\/ja00039a096","volume":"114","author":"Zerkowski J.A.","year":"1992","unstructured":"Zerkowski JA, Seto CT, Whitesides GM. J Am Chem Soc, Solid-state structures of rosette and crinkled tape motifs derived from the cyanuric acid melamine lattice.,, 1992, 114,, 5473-5475,[http:\/\/dx.doi.org\/10.1021\/ja00039a096].","journal-title":"J Am Chem Soc"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1021\/cg201096c","volume":"11","author":"Das B.","year":"2011","unstructured":"Das B, Baruah JB. Cryst Growth Des, Supramolecular synthons and hydrates in stabilization of multicomponent crystals of nicotinamide and isonicotinamide with N-containing aromatic dicarboxylic acids.,, 2011, 11,, 5522-5532,[http:\/\/dx.doi.org\/10.1021\/cg201096c].","journal-title":"Cryst Growth Des"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1021\/mp070004b","volume":"4","author":"Bu\u010dar D-K.","year":"2007","unstructured":"Bu\u010dar D-K, Henry RF, Lou X. Mol Pharm, Co-crystals of caffeine and hydroxy-2-naphthoic acids: unusual formation of the carboxylic acid dimer in the presence of a heterosynthon.,, 2007, 4,, 339-346,[http:\/\/dx.doi.org\/10.1021\/mp070004b]. [PMID: 17489605].","journal-title":"Mol Pharm"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/cg800632r","volume":"9","author":"Jayasankar A.","year":"2009","unstructured":"Jayasankar A, Reddy LS, Bethune SJ, Rodr\u00edguez-Hornedo N. Cryst Growth Des, Role of cocrystal and solution chemistry on the formation and stability of cocrystals with different stoichiometry.,, 2009, 9,, 889-897,[http:\/\/dx.doi.org\/10.1021\/cg800632r].","journal-title":"Cryst Growth Des"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1081\/DDC-120014575","volume":"28","author":"Rasenack N.","year":"2002","unstructured":"Rasenack N, M\u00fcller BW. Drug Dev Ind Pharm, Properties of ibuprofen crystallized under various conditions: a comparative study.,, 2002, 28,, 1077-1089,[http:\/\/dx.doi.org\/10.1081\/DDC-120014575]. [PMID: 12455467].","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=117","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.addr.2003.10.020","volume":"56","author":"Morissette S.L.","year":"2004","unstructured":"Morissette SL, Almarsson O, Peterson ML. Adv Drug Deliv Rev, High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.,, 2004, 56,, 275-300,[http:\/\/dx.doi.org\/10.1016\/j.addr.2003.10.020]. [PMID: 14962582].","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejpb.2006.12.016","volume":"67","author":"Hickey M.B.","year":"2007","unstructured":"Hickey MB, Peterson ML, Scoppettuolo LA. Eur J Pharm Biopharm, Performance comparison of a co-crystal of carbamazepine with marketed product.,, 2007, 67,, 112-119,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2006.12.016]. [PMID: 17292592].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=119","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1021\/mp200209j","volume":"8","author":"Smith A.J.","year":"2011","unstructured":"Smith AJ, Kavuru P, Wojtas L, Zaworotko MJ, Shytle RD. Mol Pharm, Cocrystals of quercetin with improved solubility and oral bioavailability.,, 2011, 8,, 1867-1876,[http:\/\/dx.doi.org\/10.1021\/mp200209j]. [PMID: 21846121].","journal-title":"Mol Pharm"},{"key":"ref=120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.07.037","volume":"419","author":"Qiao N.","year":"2011","unstructured":"Qiao N, Li M, Schlindwein W, Malek N, Davies A, Trappitt G. Int J Pharm, Pharmaceutical cocrystals: an overview.,, 2011, 419,, 1-11,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2011.07.037]. [PMID: 21827842].","journal-title":"Int J Pharm"},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"e3585","DOI":"10.1097\/MD.0000000000003585","volume":"95","author":"Xu C.","year":"2016","unstructured":"Xu C, Gu K, Yasen Y, Hou Y. Medicine, Efficacy and safety of celecoxib therapy in osteoarthritis: A meta-analysis of randomized controlled trials.,, 2016, 95,, e3585-,[http:\/\/dx.doi.org\/10.1097\/MD.0000000000003585]. [PMID: 27196460].","journal-title":"Medicine"},{"key":"ref=122","author":"Bensen W.G.","year":"1999","unstructured":"Bensen WG, Fiechtner JJ, McMillen JI, Zhao WW, Shawn SY, Woods EM. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial Mayo Clinic Proceedings, ,, 1999, 95,, e3585-,","journal-title":"Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial Mayo Clinic Proceedings"},{"key":"ref=123","first-page":"362","volume":"61","author":"Mutalik S.","year":"2007","unstructured":"Mutalik S, Usha N, Ranjith AK, Umesh S, Musmade P, Anup N. PDA J Pharm Sci Technol, Preparation and physicochemical and preclinical evaluations of recrystallized celecoxib.,, 2007, 61,, 362-374,[PMID: 18047175].","journal-title":"PDA J Pharm Sci Technol"},{"key":"ref=124","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1208\/s12249-016-0667-z","volume":"18","author":"Cao M.","year":"2017","unstructured":"Cao M, Ren L, Chen G. AAPS PharmSciTech, Formulation optimization and  and  evaluation of celecoxib microemulsion-based gel for transdermal delivery.,, 2017, 18,, 1960-1971,[http:\/\/dx.doi.org\/10.1208\/s12249-016-0667-z]. [PMID: 27914040].","journal-title":"AAPS PharmSciTech"},{"key":"ref=125","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/jps.20906","volume":"96","author":"Guzm\u00e1n H.R.","year":"2007","unstructured":"Guzm\u00e1n HR, Tawa M, Zhang Z. J Pharm Sci, Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations.,, 2007, 96,, 2686-2702,[http:\/\/dx.doi.org\/10.1002\/jps.20906]. [PMID: 17518357].","journal-title":"J Pharm Sci"},{"key":"ref=126","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/mp049938f","volume":"1","author":"Gupta P.","year":"2004","unstructured":"Gupta P, Chawla G, Bansal AK. Mol Pharm, Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility.,, 2004, 1,, 406-413,[http:\/\/dx.doi.org\/10.1021\/mp049938f]. [PMID: 16028352].","journal-title":"Mol Pharm"},{"key":"ref=127","first-page":"638","volume":"297","author":"Paulson S.K.","year":"2001","unstructured":"Paulson SK, Vaughn MB, Jessen SM. J Pharmacol Exp Ther, Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption.,, 2001, 297,, 638-645,[PMID: 11303053].","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=128","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1002\/jps.24048","volume":"103","author":"Huang Y.","year":"2014","unstructured":"Huang Y, Zhang B, Gao Y, Zhang J, Shi L. J Pharm Sci, Baicalein-nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailability.,, 2014, 103,, 2330-2337,[http:\/\/dx.doi.org\/10.1002\/jps.24048]. [PMID: 24903146].","journal-title":"J Pharm Sci"},{"key":"ref=129","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1021\/mp400176y","volume":"10","author":"Childs S.L.","year":"2013","unstructured":"Childs SL, Kandi P, Lingireddy SR. Mol Pharm, Formulation of a danazol cocrystal with controlled supersaturation plays an essential role in improving bioavailability.,, 2013, 10,, 3112-3127,[http:\/\/dx.doi.org\/10.1021\/mp400176y]. [PMID: 23822591].","journal-title":"Mol Pharm"},{"key":"ref=130","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijbiomac.2014.12.038","volume":"74","author":"Ganesh M.","year":"2015","unstructured":"Ganesh M, Jeon UJ, Ubaidulla U. Int J Biol Macromol, Chitosan cocrystals embedded alginate beads for enhancing the solubility and bioavailability of aceclofenac.,, 2015, 74,, 310-317,[http:\/\/dx.doi.org\/10.1016\/j.ijbiomac.2014.12.038]. [PMID: 25557368].","journal-title":"Int J Biol Macromol"},{"key":"ref=131","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1111\/j.2042-7158.2010.01189.x","volume":"62","author":"Jung M.S.","year":"2010","unstructured":"Jung MS, Kim JS, Kim MS. J Pharm Pharmacol, Bioavailability of indomethacin-saccharin cocrystals.,, 2010, 62,, 1560-1568,[http:\/\/dx.doi.org\/10.1111\/j.2042-7158.2010.01189.x]. [PMID: 21039541].","journal-title":"J Pharm Pharmacol"},{"key":"ref=132","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3109\/03639045.2015.1096281","volume":"42","author":"Ullah M.","year":"2016","unstructured":"Ullah M, Hussain I, Sun CC. Drug Dev Ind Pharm, The development of carbamazepine-succinic acid cocrystal tablet formulations with improved  and  performance.,, 2016, 42,, 969-976,[http:\/\/dx.doi.org\/10.3109\/03639045.2015.1096281]. [PMID: 26460090].","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=133","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejpb.2016.07.008","volume":"107","author":"Liu M.","year":"2016","unstructured":"Liu M, Hong C, Yao Y. Eur J Pharm Biopharm, Development of a pharmaceutical cocrystal with solution crystallization technology: Preparation, characterization, and evaluation of myricetin-proline cocrystals.,, 2016, 107,, 151-159,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2016.07.008]. [PMID: 27395394].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=134","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.bmcl.2015.01.022","volume":"25","author":"Wang J-R.","year":"2015","unstructured":"Wang J-R, Yu X, Zhou C. Bioorg Med Chem Lett, Improving the dissolution and bioavailability of 6-mercaptopurine via co-crystallization with isonicotinamide.,, 2015, 25,, 1036-1039,[http:\/\/dx.doi.org\/10.1016\/j.bmcl.2015.01.022]. [PMID: 25630224].","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=135","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/jps.24534","volume":"104","author":"Stavropoulos K.","year":"2015","unstructured":"Stavropoulos K, Johnston SC, Zhang Y. J Pharm Sci, Cocrystalline solids of telaprevir with enhanced oral absorption.,, 2015, 104,, 3343-3350,[http:\/\/dx.doi.org\/10.1002\/jps.24534]. [PMID: 26094780].","journal-title":"J Pharm Sci"},{"key":"ref=136","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ejps.2017.09.020","volume":"109","author":"Huang Y.","year":"2017","unstructured":"Huang Y, Li J-M, Lai Z-H, Wu J, Lu T-B, Chen J-M. Eur J Pharm Sci, Phenazopyridine-phthalimide nano-cocrystal: Release rate and oral bioavailability enhancement.,, 2017, 109,, 581-586,[http:\/\/dx.doi.org\/10.1016\/j.ejps.2017.09.020]. [PMID: 28917964].","journal-title":"Eur J Pharm Sci"},{"key":"ref=137","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1208\/s12249-012-9866-4","volume":"13","author":"Ober C.A.","year":"2012","unstructured":"Ober CA, Gupta RB. AAPS PharmSciTech, Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.,, 2012, 13,, 1396-1406,[http:\/\/dx.doi.org\/10.1208\/s12249-012-9866-4]. [PMID: 23054991].","journal-title":"AAPS PharmSciTech"},{"key":"ref=138","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1021\/mp400516b","volume":"10","author":"Sanphui P.","year":"2013","unstructured":"Sanphui P, Tothadi S, Ganguly S, Desiraju GR. Mol Pharm, Salt and cocrystals of sildenafil with dicarboxylic acids: solubility and pharmacokinetic advantage of the glutarate salt.,, 2013, 10,, 4687-4697,[http:\/\/dx.doi.org\/10.1021\/mp400516b]. [PMID: 24168322].","journal-title":"Mol Pharm"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1039\/C6CC00975A","volume":"52","author":"Suresh K.","year":"2016","unstructured":"Suresh K, Mannava MK, Nangia A. Chem Commun (Camb), Cocrystals and alloys of nitazoxanide: enhanced pharmacokinetics.,, 2016, 52,, 4223-4226,[http:\/\/dx.doi.org\/10.1039\/C6CC00975A]. [PMID: 26911515].","journal-title":"Chem Commun (Camb)"},{"key":"ref=140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejpb.2017.12.016","volume":"124","author":"Liu C.","year":"2018","unstructured":"Liu C, Liu Z, Chen Y. Eur J Pharm Biopharm, Oral bioavailability enhancement of \u03b2-lapachone, a poorly soluble fast crystallizer, by cocrystal, amorphous solid dispersion, and crystalline solid dispersion.,, 2018, 124,, 73-81,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2017.12.016]. [PMID: 29305142].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=141","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s11095-013-1181-6","volume":"31","author":"Lin Y.","year":"2014","unstructured":"Lin Y, Yang H, Yang C, Wang J. Pharm Res, Preparation, characterization, and evaluation of dipfluzine-benzoic acid co-crystals with improved physicochemical properties.,, 2014, 31,, 566-578,[http:\/\/dx.doi.org\/10.1007\/s11095-013-1181-6]. [PMID: 24065588].","journal-title":"Pharm Res"},{"key":"ref=142","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1002\/jps.23721","volume":"102","author":"Bruni G.","year":"2013","unstructured":"Bruni G, Maietta M, Maggi L. J Pharm Sci, Preparation and physicochemical characterization of acyclovir cocrystals with improved dissolution properties.,, 2013, 102,, 4079-4086,[http:\/\/dx.doi.org\/10.1002\/jps.23721]. [PMID: 24030886].","journal-title":"J Pharm Sci"},{"key":"ref=143","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/10837450.2016.1242625","volume":"23","author":"Arafa M.F.","year":"2018","unstructured":"Arafa MF, El-Gizawy SA, Osman MA, El Maghraby GM. Pharm Dev Technol, Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets.,, 2018, 23,, 454-463,[http:\/\/dx.doi.org\/10.1080\/10837450.2016.1242625]. [PMID: 27681386].","journal-title":"Pharm Dev Technol"},{"key":"ref=144","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1208\/s12249-018-1152-7","volume":"19","author":"Abbas N.","year":"2018","unstructured":"Abbas N, Latif S, Afzal H. AAPS PharmSciTech, Simultaneously Improving Mechanical, Formulation, and  performance of naproxen by co-crystallization.,, 2018, 19,, 3249-3257,[http:\/\/dx.doi.org\/10.1208\/s12249-018-1152-7]. [PMID: 30194682].","journal-title":"AAPS PharmSciTech"},{"key":"ref=145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11648\/j.ajhr.20170501.11","volume":"5","author":"Ali H.S.","year":"2017","unstructured":"Ali HS, Khan GA, Elhaj BM. Am J Pharm Health Res, Approaches to Enhance Dissolution In Pharmaceutical Technologies.,, 2017, 5,, 1-15,","journal-title":"Am J Pharm Health Res"},{"key":"ref=146","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2004.07.010","volume":"285","author":"Mohammed A.R.","year":"2004","unstructured":"Mohammed AR, Weston N, Coombes AG, Fitzgerald M, Perrie Y. Int J Pharm, Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.,, 2004, 285,, 23-34,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2004.07.010]. [PMID: 15488676].","journal-title":"Int J Pharm"},{"key":"ref=147","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejpb.2004.06.009","volume":"59","author":"Zhang J.A.","year":"2005","unstructured":"Zhang JA, Anyarambhatla G, Ma L. Eur J Pharm Biopharm, Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation.,, 2005, 59,, 177-187,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2004.06.009]. [PMID: 15567316].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=148","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0003-9861(85)90498-9","volume":"242","author":"Crowe L.M.","year":"1985","unstructured":"Crowe LM, Crowe JH, Rudolph A, Womersley C, Appel L. Arch Biochem Biophys, Preservation of freeze-dried liposomes by trehalose.,, 1985, 242,, 240-247,[http:\/\/dx.doi.org\/10.1016\/0003-9861(85)90498-9]. [PMID: 4051504].","journal-title":"Arch Biochem Biophys"},{"key":"ref=149","first-page":"25","volume":"3","author":"Ghanbarzadeh S.","year":"2013","unstructured":"Ghanbarzadeh S, Valizadeh H, Zakeri-Milani P. Adv Pharm Bull, The effects of lyophilization on the physico-chemical stability of sirolimus liposomes.,, 2013, 3,, 25-29,[PMID: 24312808].","journal-title":"Adv Pharm Bull"},{"key":"ref=150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10717540601098799","volume":"14","author":"Yang T.","year":"2007","unstructured":"Yang T, Cui F-D, Choi M-K. Drug Deliv, Liposome formulation of paclitaxel with enhanced solubility and stability.,, 2007, 14,, 301-308,[http:\/\/dx.doi.org\/10.1080\/10717540601098799]. [PMID: 17613018].","journal-title":"Drug Deliv"},{"key":"ref=151","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijpharm.2007.02.011","volume":"338","author":"Yang T.","year":"2007","unstructured":"Yang T, Cui F-D, Choi M-K. Int J Pharm, Enhanced solubility and stability of PEGylated liposomal paclitaxel:  and  evaluation.,, 2007, 338,, 317-326,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2007.02.011]. [PMID: 17368984].","journal-title":"Int J Pharm"},{"key":"ref=152","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12272-014-0481-7","volume":"38","author":"Zhu Y.","year":"2015","unstructured":"Zhu Y, Wang M, Zhang J. Arch Pharm Res, Improved oral bioavailability of capsaicin  liposomal nanoformulation: preparation,  drug release and pharmacokinetics in rats.,, 2015, 38,, 512-521,[http:\/\/dx.doi.org\/10.1007\/s12272-014-0481-7]. [PMID: 25231341].","journal-title":"Arch Pharm Res"},{"key":"ref=153","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.pharep.2014.04.007","volume":"66","author":"Kumar N.","year":"2014","unstructured":"Kumar N, Rai A, Reddy ND. Pharmacol Rep, Silymarin liposomes improves oral bioavailability of silybin besides targeting hepatocytes, and immune cells.,, 2014, 66,, 788-798,[http:\/\/dx.doi.org\/10.1016\/j.pharep.2014.04.007]. [PMID: 25149982].","journal-title":"Pharmacol Rep"},{"key":"ref=154","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/apmc.1984.051230121","volume":"123","author":"Bader H.","year":"1984","unstructured":"Bader H, Ringsdorf H, Schmidt B. Appl Macromol Chem Phy, Watersoluble polymers in medicine.,, 1984, 123,, 457-485,[http:\/\/dx.doi.org\/10.1002\/apmc.1984.051230121].","journal-title":"Appl Macromol Chem Phy"},{"key":"ref=155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2005.09.034","volume":"109","author":"Gaucher G.","year":"2005","unstructured":"Gaucher G, Dufresne M-H, Sant VP, Kang N, Maysinger D, Leroux J-C. J Control Release, Block copolymer micelles: preparation, characterization and application in drug delivery.,, 2005, 109,, 169-188,[http:\/\/dx.doi.org\/10.1016\/j.jconrel.2005.09.034]. [PMID: 16289422].","journal-title":"J Control Release"},{"key":"ref=156","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.addr.2003.12.004","volume":"56","author":"Lukyanov A.N.","year":"2004","unstructured":"Lukyanov AN, Torchilin VP. Adv Drug Deliv Rev, Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.,, 2004, 56,, 1273-1289,[http:\/\/dx.doi.org\/10.1016\/j.addr.2003.12.004]. [PMID: 15109769].","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=157","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1007\/s00018-004-4153-5","volume":"61","author":"Torchilin V.P.","year":"2004","unstructured":"Torchilin VP. Cell Mol Life Sci, Targeted polymeric micelles for delivery of poorly soluble drugs.,, 2004, 61,, 2549-2559,[http:\/\/dx.doi.org\/10.1007\/s00018-004-4153-5]. [PMID: 15526161].","journal-title":"Cell Mol Life Sci"},{"key":"ref=158","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0939-6411(99)00039-9","volume":"48","author":"Jones M.","year":"1999","unstructured":"Jones M, Leroux J. Eur J Pharm Biopharm, Polymeric micelles - a new generation of colloidal drug carriers.,, 1999, 48,, 101-111,[http:\/\/dx.doi.org\/10.1016\/S0939-6411(99)00039-9]. [PMID: 10469928].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=159","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0169-409X(96)00401-2","volume":"21","author":"Kwon G.S.","year":"1996","unstructured":"Kwon GS, Okano T. Adv Drug Deliv Rev, Polymeric micelles as new drug carriers.,, 1996, 21,, 107-116,[http:\/\/dx.doi.org\/10.1016\/S0169-409X(96)00401-2].","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=160","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1021\/bm060307b","volume":"8","author":"Lee S.C.","year":"2007","unstructured":"Lee SC, Huh KM, Lee J, Cho YW, Galinsky RE, Park K. Biomacromolecules, Hydrotropic polymeric micelles for enhanced paclitaxel solubility:  and  characterization.,, 2007, 8,, 202-208,[http:\/\/dx.doi.org\/10.1021\/bm060307b]. [PMID: 17206808].","journal-title":"Biomacromolecules"},{"key":"ref=161","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jconrel.2009.04.024","volume":"140","author":"Shin H-C.","year":"2009","unstructured":"Shin H-C, Alani AW, Rao DA, Rockich NC, Kwon GS. J Control Release, Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs.,, 2009, 140,, 294-300,[http:\/\/dx.doi.org\/10.1016\/j.jconrel.2009.04.024]. [PMID: 19409432].","journal-title":"J Control Release"},{"key":"ref=162","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-3659(97)00245-9","volume":"53","author":"Yu B.G.","year":"1998","unstructured":"Yu BG, Okano T, Kataoka K, Kwon G. J Control Release, Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B.,, 1998, 53,, 131-136,[http:\/\/dx.doi.org\/10.1016\/S0168-3659(97)00245-9]. [PMID: 9741920].","journal-title":"J Control Release"},{"key":"ref=163","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/BF02980249","volume":"30","author":"Kwon S.H.","year":"2007","unstructured":"Kwon SH, Kim SY, Ha KW. Arch Pharm Res, Pharmaceutical evaluation of genistein-loaded pluronic micelles for oral delivery.,, 2007, 30,, 1138-1143,[http:\/\/dx.doi.org\/10.1007\/BF02980249]. [PMID: 17958332].","journal-title":"Arch Pharm Res"},{"key":"ref=164","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jbm.a.30490","volume":"75","author":"Pierri E.","year":"2005","unstructured":"Pierri E, Avgoustakis K. J Biomed Mater Res A, Poly(lactide)-poly(ethylene glycol) micelles as a carrier for griseofulvin.,, 2005, 75,, 639-647,[http:\/\/dx.doi.org\/10.1002\/jbm.a.30490]. [PMID: 16110497].","journal-title":"J Biomed Mater Res A"},{"key":"ref=165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-3659(97)00124-7","volume":"51","author":"Kim S.Y.","year":"1998","unstructured":"Kim SY, Shin IG, Lee YM, Cho CS, Sung YK. J Control Release, Methoxy poly(ethylene glycol) and \u03f5-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviours.,, 1998, 51,, 13-22,[http:\/\/dx.doi.org\/10.1016\/S0168-3659(97)00124-7]. [PMID: 9685900].","journal-title":"J Control Release"},{"key":"ref=166","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jconrel.2005.02.010","volume":"104","author":"Sant V.P.","year":"2005","unstructured":"Sant VP, Smith D, Leroux J-C. J Control Release, Enhancement of oral bioavailability of poorly water-soluble drugs by poly(ethylene glycol)-block-poly(alkyl acrylate-co-methacrylic acid) self-assemblies.,, 2005, 104,, 289-300,[http:\/\/dx.doi.org\/10.1016\/j.jconrel.2005.02.010]. [PMID: 15907580].","journal-title":"J Control Release"},{"key":"ref=167","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1021\/bm2018382","volume":"13","author":"Liu X.","year":"2012","unstructured":"Liu X, Ma R, Shen J, Xu Y, An Y, Shi L. Biomacromolecules, Controlled release of ionic drugs from complex micelles with charged channels.,, 2012, 13,, 1307-1314,[http:\/\/dx.doi.org\/10.1021\/bm2018382]. [PMID: 22428577].","journal-title":"Biomacromolecules"},{"key":"ref=168","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jconrel.2006.10.001","volume":"117","author":"Yi Y.","year":"2007","unstructured":"Yi Y, Yoon HJ, Kim BO. J Control Release, A mixed polymeric micellar formulation of itraconazole: Characteristics, toxicity and pharmacokinetics.,, 2007, 117,, 59-67,[http:\/\/dx.doi.org\/10.1016\/j.jconrel.2006.10.001]. [PMID: 17097755].","journal-title":"J Control Release"},{"key":"ref=169","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1211\/0022357044427","volume":"56","author":"Alakhov V.","year":"2004","unstructured":"Alakhov V, Pietrzynski G, Patel K, Kabanov A, Bromberg L, Hatton TA. J Pharm Pharmacol, Pluronic block copolymers and Pluronic poly(acrylic acid) microgels in oral delivery of megestrol acetate.,, 2004, 56,, 1233-1241,[http:\/\/dx.doi.org\/10.1211\/0022357044427]. [PMID: 15482637].","journal-title":"J Pharm Pharmacol"},{"key":"ref=170","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nano.2011.01.017","volume":"7","author":"Chiappetta D.A.","year":"2011","unstructured":"Chiappetta DA, Facorro G, de Celis ER, Sosnik A. Nanomedicine (Lond), Synergistic encapsulation of the anti-HIV agent efavirenz within mixed poloxamine\/poloxamer polymeric micelles.,, 2011, 7,, 624-637,[http:\/\/dx.doi.org\/10.1016\/j.nano.2011.01.017]. [PMID: 21371572].","journal-title":"Nanomedicine (Lond)"},{"key":"ref=171","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.colsurfb.2013.09.010","volume":"114","author":"Dou J.","year":"2014","unstructured":"Dou J, Zhang H, Liu X, Zhang M, Zhai G. Colloids Surf B Biointerfaces, Preparation and evaluation  and  of docetaxel loaded mixed micelles for oral administration.,, 2014, 114,, 20-27,[http:\/\/dx.doi.org\/10.1016\/j.colsurfb.2013.09.010]. [PMID: 24157590].","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=172","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1021\/mp100033k","volume":"7","author":"Zhang Y.","year":"2010","unstructured":"Zhang Y, Li X, Zhou Y. Mol Pharm, Cyclosporin A-loaded poly(ethylene glycol)-b-poly(d,l-lactic acid) micelles: preparation,  and  characterization and transport mechanism across the intestinal barrier.,, 2010, 7,, 1169-1182,[http:\/\/dx.doi.org\/10.1021\/mp100033k]. [PMID: 20540526].","journal-title":"Mol Pharm"},{"key":"ref=173","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jconrel.2004.04.007","volume":"97","author":"Barreiro-Iglesias R.","year":"2004","unstructured":"Barreiro-Iglesias R, Bromberg L, Temchenko M, Hatton TA, Concheiro A, Alvarez-Lorenzo C. J Control Release, Solubilization and stabilization of camptothecin in micellar solutions of pluronic-g-poly(acrylic acid) copolymers.,, 2004, 97,, 537-549,[http:\/\/dx.doi.org\/10.1016\/j.jconrel.2004.04.007]. [PMID: 15212885].","journal-title":"J Control Release"},{"key":"ref=174","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2006.02.018","volume":"315","author":"Dabholkar R.D.","year":"2006","unstructured":"Dabholkar RD, Sawant RM, Mongayt DA, Devarajan PV, Torchilin VP. Int J Pharm, Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux.,, 2006, 315,, 148-157,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2006.02.018]. [PMID: 16616818].","journal-title":"Int J Pharm"},{"key":"ref=175","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1016\/j.biomaterials.2011.03.005","volume":"32","author":"Mo R.","year":"2011","unstructured":"Mo R, Jin X, Li N. Biomaterials, The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles.,, 2011, 32,, 4609-4620,[http:\/\/dx.doi.org\/10.1016\/j.biomaterials.2011.03.005]. [PMID: 21440934].","journal-title":"Biomaterials"},{"key":"ref=176","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jconrel.2004.10.022","volume":"102","author":"Ould-Ouali L.","year":"2005","unstructured":"Ould-Ouali L, Noppe M, Langlois X. J Control Release, Self-assembling PEG-p(CL-co-TMC) copolymers for oral delivery of poorly water-soluble drugs: a case study with risperidone.,, 2005, 102,, 657-668,[http:\/\/dx.doi.org\/10.1016\/j.jconrel.2004.10.022]. [PMID: 15681087].","journal-title":"J Control Release"},{"key":"ref=177","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/21691401.2012.742100","volume":"41","author":"Kim M-S.","year":"2013","unstructured":"Kim M-S, Kim J-S, Cho WK, Hwang S-J. Artif Cells Nanomed Biotechnol, Enhanced solubility and oral absorption of sirolimus using D-\u03b1-tocopheryl polyethylene glycol succinate micelles.,, 2013, 41,, 85-91,[http:\/\/dx.doi.org\/10.3109\/21691401.2012.742100]. [PMID: 23305536].","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=178","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.drudis.2008.04.006","volume":"13","author":"Tang B.","year":"2008","unstructured":"Tang B, Cheng G, Gu J-C, Xu C-H. Drug Discov Today, Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms.,, 2008, 13,, 606-612,[http:\/\/dx.doi.org\/10.1016\/j.drudis.2008.04.006]. [PMID: 18598917].","journal-title":"Drug Discov Today"},{"key":"ref=179","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejpb.2008.05.001","volume":"70","author":"Yi T.","year":"2008","unstructured":"Yi T, Wan J, Xu H, Yang X. Eur J Pharm Biopharm, A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs.,, 2008, 70,, 439-444,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2008.05.001]. [PMID: 18603415].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=180","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/02652048.2011.651497","volume":"29","author":"Kim D.W.","year":"2012","unstructured":"Kim DW, Kang JH, Oh DH, Yong CS, Choi H-G. J Microencapsul, Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier.,, 2012, 29,, 323-330,[http:\/\/dx.doi.org\/10.3109\/02652048.2011.651497]. [PMID: 22233141].","journal-title":"J Microencapsul"},{"key":"ref=181","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ejpb.2009.03.001","volume":"72","author":"Balakrishnan P.","year":"2009","unstructured":"Balakrishnan P, Lee B-J, Oh DH. Eur J Pharm Biopharm, Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS).,, 2009, 72,, 539-545,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2009.03.001]. [PMID: 19298857].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=182","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1248\/bpb.34.278","volume":"34","author":"Chen Y.","year":"2011","unstructured":"Chen Y, Chen C, Zheng J, Chen Z, Shi Q, Liu H. Biol Pharm Bull, Development of a solid supersaturatable self-emulsifying drug delivery system of docetaxel with improved dissolution and bioavailability.,, 2011, 34,, 278-286,[http:\/\/dx.doi.org\/10.1248\/bpb.34.278]. [PMID: 21415541].","journal-title":"Biol Pharm Bull"},{"key":"ref=183","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1248\/bpb.34.1179","volume":"34","author":"Yan Y-D.","year":"2011","unstructured":"Yan Y-D, Kim JA, Kwak MK, Yoo BK, Yong CS, Choi H-G. Biol Pharm Bull, Enhanced oral bioavailability of curcumin  a solid lipid-based self-emulsifying drug delivery system using a spray-drying technique.,, 2011, 34,, 1179-1186,[http:\/\/dx.doi.org\/10.1248\/bpb.34.1179]. [PMID: 21804203].","journal-title":"Biol Pharm Bull"},{"key":"ref=184","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3109\/03639045.2012.729594","volume":"39","author":"Agarwal V.","year":"2013","unstructured":"Agarwal V, Alayoubi A, Siddiqui A, Nazzal S. Drug Dev Ind Pharm, Powdered self-emulsified lipid formulations of meloxicam as solid dosage forms for oral administration.,, 2013, 39,, 1681-1689,[http:\/\/dx.doi.org\/10.3109\/03639045.2012.729594]. [PMID: 23072611].","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/02652048.2013.843601","volume":"31","author":"Kanaujia P.","year":"2014","unstructured":"Kanaujia P, Ng WK, Tan RB. J Microencapsul, Solid self-emulsifying drug delivery system (S-SEDDS) for improved dissolution rate of fenofibrate.,, 2014, 31,, 293-298,[http:\/\/dx.doi.org\/10.3109\/02652048.2013.843601]. [PMID: 24156747].","journal-title":"J Microencapsul"},{"key":"ref=186","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/jps.10511","volume":"92","author":"Gao P.","year":"2003","unstructured":"Gao P, Rush BD, Pfund WP. J Pharm Sci, Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability.,, 2003, 92,, 2386-2398,[http:\/\/dx.doi.org\/10.1002\/jps.10511]. [PMID: 14603484].","journal-title":"J Pharm Sci"},{"key":"ref=187","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3109\/03639045.2011.571695","volume":"37","author":"Kang M.J.","year":"2011","unstructured":"Kang MJ, Jung SY, Song WH. Drug Dev Ind Pharm, Immediate release of ibuprofen from Fujicalin-based fast-dissolving self-emulsifying tablets.,, 2011, 37,, 1298-1305,[http:\/\/dx.doi.org\/10.3109\/03639045.2011.571695]. [PMID: 21476949].","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=188","first-page":"11","author":"Robinson J.","year":"1996","unstructured":"Robinson J. Introduction: semi-solid formulations of oral drug delivery, ,, 1996, 37,, 11-14,","journal-title":"Introduction: semi-solid formulations of oral drug delivery"},{"key":"ref=189","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijpharm.2015.09.011","volume":"495","author":"Chavan R.B.","year":"2015","unstructured":"Chavan RB, Modi SR, Bansal AK. Int J Pharm, Role of solid carriers in pharmaceutical performance of solid supersaturable SEDDS of celecoxib.,, 2015, 495,, 374-384,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2015.09.011]. [PMID: 26364711].","journal-title":"Int J Pharm"},{"key":"ref=190","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2008.08.046","volume":"366","author":"Agarwal V.","year":"2009","unstructured":"Agarwal V, Siddiqui A, Ali H, Nazzal S. Int J Pharm, Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS).,, 2009, 366,, 44-52,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2008.08.046]. [PMID: 18832019].","journal-title":"Int J Pharm"},{"key":"ref=191","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejpb.2015.01.011","volume":"91","author":"Weerapol Y.","year":"2015","unstructured":"Weerapol Y, Limmatvapirat S, Jansakul C, Takeuchi H, Sriamornsak P. Eur J Pharm Biopharm, Enhanced dissolution and oral bioavailability of nifedipine by spontaneous emulsifying powders: effect of solid carriers and dietary state.,, 2015, 91,, 25-34,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2015.01.011]. [PMID: 25615879].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=192","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1208\/s12249-009-9347-6","volume":"11","author":"Nekkanti V.","year":"2010","unstructured":"Nekkanti V, Karatgi P, Prabhu R, Pillai R. AAPS PharmSciTech, Solid self-microemulsifying formulation for candesartan cilexetil.,, 2010, 11,, 9-17,[http:\/\/dx.doi.org\/10.1208\/s12249-009-9347-6]. [PMID: 20013081].","journal-title":"AAPS PharmSciTech"},{"key":"ref=193","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1208\/s12249-014-0247-z","volume":"16","author":"Krupa A.","year":"2015","unstructured":"Krupa A, Szl\u0119k J, Jany BR, Jachowicz R. AAPS PharmSciTech, Preformulation studies on solid self-emulsifying systems in powder form containing magnesium aluminometasilicate as porous carrier.,, 2015, 16,, 623-635,[http:\/\/dx.doi.org\/10.1208\/s12249-014-0247-z]. [PMID: 25501870].","journal-title":"AAPS PharmSciTech"},{"key":"ref=194","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1515\/acph-2015-0003","volume":"65","author":"Shazly G.","year":"2015","unstructured":"Shazly G, Mohsin K. Acta Pharm, Dissolution improvement of solid self-emulsifying drug delivery systems of fenofibrate using an inorganic high surface adsorption material.,, 2015, 65,, 29-42,[http:\/\/dx.doi.org\/10.1515\/acph-2015-0003]. [PMID: 25781702].","journal-title":"Acta Pharm"},{"key":"ref=195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2005.03.017","volume":"105","author":"Ito Y.","year":"2005","unstructured":"Ito Y, Kusawake T, Ishida M, Tawa R, Shibata N, Takada K. J Control Release, Oral solid gentamicin preparation using emulsifier and adsorbent.,, 2005, 105,, 23-31,[http:\/\/dx.doi.org\/10.1016\/j.jconrel.2005.03.017]. [PMID: 15908031].","journal-title":"J Control Release"},{"key":"ref=196","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijpharm.2012.06.032","volume":"436","author":"Milovi\u0107 M.","year":"2012","unstructured":"Milovi\u0107 M, Djuri\u0161 J, Djeki\u0107 L, Vasiljevi\u0107 D, Ibri\u0107 S. Int J Pharm, Characterization and evaluation of solid self-microemulsifying drug delivery systems with porous carriers as systems for improved carbamazepine release.,, 2012, 436,, 58-65,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2012.06.032]. [PMID: 22721847].","journal-title":"Int J Pharm"},{"key":"ref=197","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.colsurfb.2012.06.031","volume":"101","author":"Beg S.","year":"2013","unstructured":"Beg S, Jena SS, Patra ChN. Colloids Surf B Biointerfaces, Development of solid self-nanoemulsifying granules (SSNEGs) of ondansetron hydrochloride with enhanced bioavailability potential.,, 2013, 101,, 414-423,[http:\/\/dx.doi.org\/10.1016\/j.colsurfb.2012.06.031]. [PMID: 23010049].","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2015.03.024","volume":"74","author":"Inugala S.","year":"2015","unstructured":"Inugala S, Eedara BB, Sunkavalli S. Eur J Pharm Sci, Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability:  and  evaluation.,, 2015, 74,, 1-10,[http:\/\/dx.doi.org\/10.1016\/j.ejps.2015.03.024]. [PMID: 25845633].","journal-title":"Eur J Pharm Sci"},{"key":"ref=199","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijpharm.2014.11.060","volume":"478","author":"Lee D.H.","year":"2015","unstructured":"Lee DH, Yeom DW, Song YS. Int J Pharm, Improved oral absorption of dutasteride  Soluplus-based supersaturable self-emulsifying drug delivery system (S-SEDDS).,, 2015, 478,, 341-347,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2014.11.060]. [PMID: 25437113].","journal-title":"Int J Pharm"},{"key":"ref=200","first-page":"1109","volume":"11","author":"Lee D.R.","year":"2016","unstructured":"Lee DR, Ho MJ, Jung HJ. Int J Nanomedicine, Enhanced dissolution and oral absorption of tacrolimus by supersaturable self-emulsifying drug delivery system.,, 2016, 11,, 1109-1117,[PMID: 27051286].","journal-title":"Int J Nanomedicine"},{"key":"ref=201","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","volume":"6","author":"Porter C.J.","year":"2007","unstructured":"Porter CJ, Trevaskis NL, Charman WN. Nat Rev Drug Discov, Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.,, 2007, 6,, 231-248,[http:\/\/dx.doi.org\/10.1038\/nrd2197]. [PMID: 17330072].","journal-title":"Nat Rev Drug Discov"},{"key":"ref=202","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/jps.2600710217","volume":"71","author":"Benita S.","year":"1982","unstructured":"Benita S, Donbrow M. J Pharm Sci, Effect of polyisobutylene on ethyl cellulose-walled microcapsules: wall structure and thickness of salicylamide and theophylline microcapsules.,, 1982, 71,, 205-210,[http:\/\/dx.doi.org\/10.1002\/jps.2600710217]. [PMID: 7062247].","journal-title":"J Pharm Sci"},{"key":"ref=203","first-page":"65","volume":"5","author":"Singh M.N.","year":"2010","unstructured":"Singh MN, Hemant KS, Ram M, Shivakumar HG. Res Pharm Sci, Microencapsulation: A promising technique for controlled drug delivery.,, 2010, 5,, 65-77,[PMID: 21589795].","journal-title":"Res Pharm Sci"},{"key":"ref=204","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3797\/scipharm.1204-16","volume":"81","author":"Mudgil M.","year":"2013","unstructured":"Mudgil M, Pawar PK. Sci Pharm, Preparation and \/ evaluation of moxifloxacin-loaded PLGA nanosuspensions for ophthalmic application.,, 2013, 81,, 591-606,[http:\/\/dx.doi.org\/10.3797\/scipharm.1204-16]. [PMID: 23833723].","journal-title":"Sci Pharm"},{"key":"ref=205","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.msec.2012.11.025","volume":"33","author":"Masood F.","year":"2013","unstructured":"Masood F, Chen P, Yasin T, Fatima N, Hasan F, Hameed A. Mater Sci Eng C, Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its  application.,, 2013, 33,, 1054-1060,[http:\/\/dx.doi.org\/10.1016\/j.msec.2012.11.025]. [PMID: 23827542].","journal-title":"Mater Sci Eng C"},{"key":"ref=206","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ejpb.2011.11.014","volume":"80","author":"Shah M.","year":"2012","unstructured":"Shah M, Ullah N, Choi MH, Kim MO, Yoon SC. Eur J Pharm Biopharm, Amorphous amphiphilic P(3HV-co-4HB)-b-mPEG block copolymer synthesized from bacterial copolyester  melt transesterification: nanoparticle preparation, cisplatin-loading for cancer therapy and  evaluation.,, 2012, 80,, 518-527,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2011.11.014]. [PMID: 22178562].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=207","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/156720110790396517","volume":"7","author":"Yadav K.S.","year":"2010","unstructured":"Yadav KS, Sawant KK. Curr Drug Deliv, Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation.,, 2010, 7,, 51-64,[http:\/\/dx.doi.org\/10.2174\/156720110790396517]. [PMID: 20044908].","journal-title":"Curr Drug Deliv"},{"key":"ref=208","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2006.12.003","volume":"117","author":"Chalasani K.B.","year":"2007","unstructured":"Chalasani KB, Russell-Jones GJ, Yandrapu SK, Diwan PV, Jain SK. J Control Release, A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin.,, 2007, 117,, 421-429,[http:\/\/dx.doi.org\/10.1016\/j.jconrel.2006.12.003]. [PMID: 17239471].","journal-title":"J Control Release"},{"key":"ref=209","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.colsurfb.2014.08.011","volume":"122","author":"Sawdon A.J.","year":"2014","unstructured":"Sawdon AJ, Peng C-A. Colloids Surf B Biointerfaces, Polymeric micelles for acyclovir drug delivery.,, 2014, 122,, 738-745,[http:\/\/dx.doi.org\/10.1016\/j.colsurfb.2014.08.011]. [PMID: 25193154].","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2008.09.086","volume":"133","author":"Danhier F.","year":"2009","unstructured":"Danhier F, Lecouturier N, Vroman B. J Control Release, Paclitaxel-loaded PEGylated PLGA-based nanoparticles:  and  evaluation.,, 2009, 133,, 11-17,[http:\/\/dx.doi.org\/10.1016\/j.jconrel.2008.09.086]. [PMID: 18950666].","journal-title":"J Control Release"},{"key":"ref=211","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nano.2009.10.004","volume":"6","author":"Gupta H.","year":"2010","unstructured":"Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Nanomedicine (Lond), Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery.,, 2010, 6,, 324-333,[http:\/\/dx.doi.org\/10.1016\/j.nano.2009.10.004]. [PMID: 19857606].","journal-title":"Nanomedicine (Lond)"},{"key":"ref=212","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejpb.2006.09.004","volume":"66","author":"Derakhshandeh K.","year":"2007","unstructured":"Derakhshandeh K, Erfan M, Dadashzadeh S. Eur J Pharm Biopharm, Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.,, 2007, 66,, 34-41,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2006.09.004]. [PMID: 17070678].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=213","doi-asserted-by":"crossref","first-page":"17356","DOI":"10.1073\/pnas.0809154105","volume":"105","author":"Dhar S.","year":"2008","unstructured":"Dhar S, Gu FX, Langer R, Farokhzad OC, Lippard SJ. Proc Natl Acad Sci USA, Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA\u2013PEG nanoparticles.,, 2008, 105,, 17356-17361,[http:\/\/dx.doi.org\/10.1073\/pnas.0809154105].","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=214","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2009.05.062","volume":"379","author":"Pu X.","year":"2009","unstructured":"Pu X, Sun J, Wang Y. Int J Pharm, Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.,, 2009, 379,, 167-173,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2009.05.062]. [PMID: 19505545].","journal-title":"Int J Pharm"},{"key":"ref=215","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1023\/A:1018970030327","volume":"10","author":"All\u00e9mann E.","year":"1993","unstructured":"All\u00e9mann E, Leroux J-C, Gurny R, Doelker E. Pharm Res, \n                         extended-release properties of drug-loaded poly(DL-lactic acid) nanoparticles produced by a salting-out procedure.,, 1993, 10,, 1732-1737,[http:\/\/dx.doi.org\/10.1023\/A:1018970030327]. [PMID: 7905625].","journal-title":"Pharm Res"},{"key":"ref=216","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s13233-010-1114-8","volume":"18","author":"Vu M-T.","year":"2010","unstructured":"Vu M-T, Jeong Y-I, Choi C, Nam J-P, Son D-H, Park J-K. Macromol Res, Surfactant-free nanoparticles of doxorubicin-conjugated poly (DL-lactide-co-glycolide).,, 2010, 18,, 1115-1120,[http:\/\/dx.doi.org\/10.1007\/s13233-010-1114-8].","journal-title":"Macromol Res"},{"key":"ref=217","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.supflu.2005.09.005","volume":"37","author":"Pathak P.","year":"2006","unstructured":"Pathak P, Meziani MJ, Desai T, Sun Y-P. J Supercrit Fluids, Formation and stabilization of ibuprofen nanoparticles in supercritical fluid processing.,, 2006, 37,, 279-286,[http:\/\/dx.doi.org\/10.1016\/j.supflu.2005.09.005].","journal-title":"J Supercrit Fluids"},{"key":"ref=218","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.colsurfb.2011.03.035","volume":"86","author":"Silva A.C.","year":"2011","unstructured":"Silva AC, Gonz\u00e1lez-Mira E, Garc\u00eda ML. Colloids Surf B Biointerfaces, Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound.,, 2011, 86,, 158-165,[http:\/\/dx.doi.org\/10.1016\/j.colsurfb.2011.03.035]. [PMID: 21530187].","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=219","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2004.02.032","volume":"278","author":"Souto E.B.","year":"2004","unstructured":"Souto EB, Wissing SA, Barbosa CM, M\u00fcller RH. Int J Pharm, Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.,, 2004, 278,, 71-77,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2004.02.032]. [PMID: 15158950].","journal-title":"Int J Pharm"},{"key":"ref=220","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpharm.2006.08.007","volume":"328","author":"Liu J.","year":"2007","unstructured":"Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X. Int J Pharm, Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.,, 2007, 328,, 191-195,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2006.08.007]. [PMID: 16978810].","journal-title":"Int J Pharm"},{"key":"ref=221","first-page":"2","volume":"2012","author":"Silpa N.","year":"2012","unstructured":"Silpa N, Chakravarthi N, Chandramouli Y, Hemanth K, Kumar P. Asian J Pharm Res, Moxifloxacin loaded solid lipid nanoparticles (SLNs): Preparation and characterization.,, 2012, 2012,, 2-,","journal-title":"Asian J Pharm Res"},{"key":"ref=222","first-page":"2338","volume":"7","author":"Verma V.K.","year":"2014","unstructured":"Verma VK, Alpana R. Int J Pharm Sci Nanotechnol, Development of piroxicam loaded SLN-based hydrogel for transdermal delivery.,, 2014, 7,, 2338-2345,","journal-title":"Int J Pharm Sci Nanotechnol"},{"key":"ref=223","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2010.10.055","volume":"404","author":"Hu J.","year":"2011","unstructured":"Hu J, Ng WK, Dong Y, Shen S, Tan RB. Int J Pharm, Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.,, 2011, 404,, 198-204,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2010.10.055]. [PMID: 21056643].","journal-title":"Int J Pharm"},{"key":"ref=224","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijpharm.2008.01.008","volume":"356","author":"Liu J.","year":"2008","unstructured":"Liu J, Gong T, Fu H. Int J Pharm, Solid lipid nanoparticles for pulmonary delivery of insulin.,, 2008, 356,, 333-344,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2008.01.008]. [PMID: 18281169].","journal-title":"Int J Pharm"},{"key":"ref=225","first-page":"376","volume":"31","author":"Chen Y.J.","year":"2006","unstructured":"Chen YJ, Jin RX, Zhou YQ, Zeng J, Zhang H, Feng QR. Zhongguo Zhongyao Zazhi, [Preparation of solid lipid nanoparticles loaded with Xionggui powder-supercritical carbon dioxide fluid extraction and their evaluation  release].,, 2006, 31,, 376-379, [PMID: 16711418].","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"ref=226","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s11095-010-0201-z","volume":"27","author":"Li Y-Z.","year":"2010","unstructured":"Li Y-Z, Sun X, Gong T, Liu J, Zuo J, Zhang Z-R. Pharm Res, Inhalable microparticles as carriers for pulmonary delivery of thymopentin-loaded solid lipid nanoparticles.,, 2010, 27,, 1977-1986,[http:\/\/dx.doi.org\/10.1007\/s11095-010-0201-z]. [PMID: 20625801].","journal-title":"Pharm Res"},{"key":"ref=227","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0939-6411(99)00058-2","volume":"49","author":"Brazel C.S.","year":"2000","unstructured":"Brazel CS, Peppas NA. Eur J Pharm Biopharm, Modeling of drug release from swellable polymers.,, 2000, 49,, 47-58,[http:\/\/dx.doi.org\/10.1016\/S0939-6411(99)00058-2]. [PMID: 10613927].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=228","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1106\/088532802024248","volume":"16","author":"Zhang Y.","year":"2002","unstructured":"Zhang Y, Chu C-C. J Biomater Appl, \n                         release behavior of insulin from biodegradable hybrid hydrogel networks of polysaccharide and synthetic biodegradable polyester.,, 2002, 16,, 305-325,[http:\/\/dx.doi.org\/10.1106\/088532802024248]. [PMID: 12099510].","journal-title":"J Biomater Appl"},{"key":"ref=229","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/S0142-9612(00)00115-0","volume":"21","author":"Jain R.A.","year":"2000","unstructured":"Jain RA. Biomaterials, The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.,, 2000, 21,, 2475-2490,[http:\/\/dx.doi.org\/10.1016\/S0142-9612(00)00115-0]. [PMID: 11055295].","journal-title":"Biomaterials"},{"key":"ref=230","author":"Jabeen M","unstructured":"Jabeen M, Begum S, Siddique A, Fatima SS. Biomaterials, Journal of Inventions\nin Biomedical and Pharmaceutical Sciences (JIBPS).,, , 21,, 2475-,"},{"key":"ref=231","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1208\/s12249-012-9752-0","volume":"13","author":"Baracat M.M.","year":"2012","unstructured":"Baracat MM, Nakagawa AM, Casagrande R, Georgetti SR, Verri WA, de Freitas O. AAPS PharmSciTech, Preparation and characterization of microcapsules based on biodegradable polymers: pectin\/casein complex for controlled drug release systems.,, 2012, 13,, 364-372,[http:\/\/dx.doi.org\/10.1208\/s12249-012-9752-0]. [PMID: 22322381].","journal-title":"AAPS PharmSciTech"},{"key":"ref=232","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tifs.2013.04.001","volume":"31","author":"Estevinho B.N.","year":"2013","unstructured":"Estevinho BN, Rocha F, Santos L, Alves A. Trends Food Sci Technol, Microencapsulation with chitosan by spray drying for industry applications\u2013A review.,, 2013, 31,, 138-155,[http:\/\/dx.doi.org\/10.1016\/j.tifs.2013.04.001].","journal-title":"Trends Food Sci Technol"},{"key":"ref=233","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.carbpol.2015.01.029","volume":"123","author":"Yang J.","year":"2015","unstructured":"Yang J, Han S, Zheng H, Dong H, Liu J. Carbohydr Polym, Preparation and application of micro\/nanoparticles based on natural polysaccharides.,, 2015, 123,, 53-66,[http:\/\/dx.doi.org\/10.1016\/j.carbpol.2015.01.029]. [PMID: 25843834].","journal-title":"Carbohydr Polym"},{"key":"ref=234","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1023\/A:1011929016601","volume":"15","author":"Illum L.","year":"1998","unstructured":"Illum L. Pharm Res, Chitosan and its use as a pharmaceutical excipient.,, 1998, 15,, 1326-1331,[http:\/\/dx.doi.org\/10.1023\/A:1011929016601]. [PMID: 9755881].","journal-title":"Pharm Res"},{"key":"ref=235","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/2230-973X.96920","volume":"2","author":"Tiwari G.","year":"2012","unstructured":"Tiwari G, Tiwari R, Sriwastawa B. Int J Pharm Investig, Drug delivery systems: An updated review.,, 2012, 2,, 2-11,[http:\/\/dx.doi.org\/10.4103\/2230-973X.96920]. [PMID: 23071954].","journal-title":"Int J Pharm Investig"},{"key":"ref=236","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jconrel.2012.03.013","volume":"160","author":"Gao L.","year":"2012","unstructured":"Gao L, Liu G, Ma J, Wang X, Zhou L, Li X. J Control Release, Drug nanocrystals:  performances.,, 2012, 160,, 418-430,[http:\/\/dx.doi.org\/10.1016\/j.jconrel.2012.03.013]. [PMID: 22465393].","journal-title":"J Control Release"},{"key":"ref=237","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd1494","volume":"3","author":"Rabinow B.E.","year":"2004","unstructured":"Rabinow BE. Nat Rev Drug Discov, Nanosuspensions in drug delivery.,, 2004, 3,, 785-796,[http:\/\/dx.doi.org\/10.1038\/nrd1494]. [PMID: 15340388].","journal-title":"Nat Rev Drug Discov"},{"key":"ref=238","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.4314\/tjpr.v7i3.14691","volume":"7","author":"Garg R.","year":"2008","unstructured":"Garg R, Gupta G. Trop J Pharm Res, Progress in controlled gastroretentive delivery systems.,, 2008, 7,, 1055-1066,[http:\/\/dx.doi.org\/10.4314\/tjpr.v7i3.14691].","journal-title":"Trop J Pharm Res"},{"key":"ref=239","first-page":"1184","volume":"1","author":"Sahil K.","year":"2011","unstructured":"Sahil K, Akanksha M, Premjeet S, Bilandi A, Kapoor B. Int J Res Pharm Chem, Microsphere: a review.,, 2011, 1,, 1184-1198,","journal-title":"Int J Res Pharm Chem"},{"key":"ref=240","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1897\/08-090.1","volume":"27","author":"Klaine S.J.","year":"2008","unstructured":"Klaine SJ, Alvarez PJ, Batley GE. Environ Toxicol Chem, Nanomaterials in the environment: behavior, fate, bioavailability, and effects.,, 2008, 27,, 1825-1851,[http:\/\/dx.doi.org\/10.1897\/08-090.1]. [PMID: 19086204].","journal-title":"Environ Toxicol Chem"},{"key":"ref=241","first-page":"274","volume":"5","author":"Shaikh S.","year":"2016","unstructured":"Shaikh S, Khan G, Shaikh S, Fakir H, Shaikh S, Shaikh M. World J Pharm Pharm Sci, Microspheres as a multiparticulate drug delivery system: A review.,, 2016, 5,, 274-292,","journal-title":"World J Pharm Pharm Sci"},{"key":"ref=242","first-page":"1467","volume":"8","author":"de la Torre-Iglesias P.M.","year":"2014","unstructured":"de la Torre-Iglesias PM, Garc\u00eda-Rodriguez JJ, Torrado G, Torrado S, Torrado-Santiago S, Bol\u00e1s-Fern\u00e1ndez F. Drug Des Devel Ther, Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose.,, 2014, 8,, 1467-1479,[PMID: 25258515].","journal-title":"Drug Des Devel Ther"},{"key":"ref=243","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijpharm.2013.07.009","volume":"454","author":"Zhang Y.","year":"2013","unstructured":"Zhang Y, Zhi Z, Li X, Gao J, Song Y. Int J Pharm, Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.,, 2013, 454,, 403-411,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2013.07.009]. [PMID: 23850816].","journal-title":"Int J Pharm"},{"key":"ref=244","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1208\/s12249-015-0460-4","volume":"17","author":"Zhu Y.","year":"2016","unstructured":"Zhu Y, Wang M, Zhang Y. AAPS PharmSciTech, \n                         release and bioavailability of silybin from micelle-templated porous calcium phosphate microparticles.,, 2016, 17,, 1232-1239,[http:\/\/dx.doi.org\/10.1208\/s12249-015-0460-4]. [PMID: 26669888].","journal-title":"AAPS PharmSciTech"},{"key":"ref=245","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ijpharm.2011.12.007","volume":"423","author":"Sui X.","year":"2012","unstructured":"Sui X, Wei W, Yang L. Int J Pharm, Preparation, characterization and  assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.,, 2012, 423,, 471-479,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2011.12.007]. [PMID: 22183131].","journal-title":"Int J Pharm"},{"key":"ref=246","first-page":"52041731414536573","author":"Yazdi I.K.","year":"2014","unstructured":"Yazdi IK, Murphy MB, Loo C. J Tissue Eng, Cefazolin-loaded mesoporous silicon microparticles show sustained bactericidal effect against ,, 2014, 423,, 52041731414536573-,[http:\/\/dx.doi.org\/10.1177\/2041731414536573]. [PMID: 24904728].","journal-title":"J Tissue Eng"},{"key":"ref=247","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/10611861003667599","volume":"19","author":"Baek J-S.","year":"2011","unstructured":"Baek J-S, Kwon H-H, Hwang J-S. J Drug Target, Alendronate-loaded microparticles for improvement of intestinal cellular absorption.,, 2011, 19,, 37-48,[http:\/\/dx.doi.org\/10.3109\/10611861003667599]. [PMID: 20477555].","journal-title":"J Drug Target"},{"key":"ref=248","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3109\/03639045.2011.643894","volume":"38","author":"Park C-W.","year":"2012","unstructured":"Park C-W, Kim J-Y, Rhee Y-S, Oh T-O, Ha J-M, Park E-S. Drug Dev Ind Pharm, Preparation and  evaluation of spray dried matrix type controlled-release microparticles of tamsulosin hydrochloride for orally disintegrating tablet.,, 2012, 38,, 1179-1187,[http:\/\/dx.doi.org\/10.3109\/03639045.2011.643894]. [PMID: 22200122].","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=249","first-page":"67","volume":"13","author":"Khonsari F.","year":"2014","unstructured":"Khonsari F, Zakeri-Milani P, Jelvehgari M. Iran J Pharm Res, Formulation and evaluation of  characterization of gastic-mucoadhesive microparticles\/discs containing metformin hydrochloride.,, 2014, 13,, 67-80,[PMID: 24734057].","journal-title":"Iran J Pharm Res"},{"key":"ref=250","first-page":"41","volume":"22","author":"Kousar R.","year":"2013","unstructured":"Kousar R, Ahmad M, Murtaza G, Khan SA, Karim S, Hussain I. Adv Clin Exp Med, Pharmacokinetic study of hydroxypropylmethylcellulose microparticles loaded with cimetidine.,, 2013, 22,, 41-45,[PMID: 23468261].","journal-title":"Adv Clin Exp Med"},{"key":"ref=251","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1208\/s12249-010-9505-x","volume":"11","author":"Khan F.","year":"2010","unstructured":"Khan F, Katara R, Ramteke S. AAPS PharmSciTech, Enhancement of bioavailability of cefpodoxime proxetil using different polymeric microparticles.,, 2010, 11,, 1368-1375,[http:\/\/dx.doi.org\/10.1208\/s12249-010-9505-x]. [PMID: 20821175].","journal-title":"AAPS PharmSciTech"},{"key":"ref=252","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/1567201811310030008","volume":"10","author":"Patel J.K.","year":"2013","unstructured":"Patel JK, Patil PS, Sutariya VB. Curr Drug Deliv, Formulation and characterization of mucoadhesive microparticles of cinnarizine hydrochloride using supercritical fluid technique.,, 2013, 10,, 317-325,[http:\/\/dx.doi.org\/10.2174\/1567201811310030008]. [PMID: 23286919].","journal-title":"Curr Drug Deliv"},{"key":"ref=253","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/10717544.2011.595841","volume":"18","author":"Ghorab D.M.","year":"2011","unstructured":"Ghorab DM, Amin MM, Khowessah OM, Tadros MI. Drug Deliv, Colon-targeted celecoxib-loaded Eudragit S100-coated poly-\u03b5-caprolactone microparticles: preparation, characterization and  evaluation in rats.,, 2011, 18,, 523-535,[http:\/\/dx.doi.org\/10.3109\/10717544.2011.595841]. [PMID: 21793779].","journal-title":"Drug Deliv"},{"key":"ref=254","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.nbt.2010.02.018","volume":"27","author":"Kim J.S.","year":"2010","unstructured":"Kim JS, Lee J-S, Chang P-S, Lee HG. N Biotechnol, Optimization,  release and bioavailability of \u03b3-oryzanol-loaded calcium pectinate microparticles reinforced with chitosan.,, 2010, 27,, 368-373,[http:\/\/dx.doi.org\/10.1016\/j.nbt.2010.02.018]. [PMID: 20193784].","journal-title":"N Biotechnol"},{"key":"ref=255","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1002\/jps.23278","volume":"101","author":"Nishino Y.","year":"2012","unstructured":"Nishino Y, Kubota A, Kanazawa T, Takashima Y, Ozeki T, Okada H. J Pharm Sci, Improved intestinal absorption of a poorly water-soluble oral drug using mannitol microparticles containing a nanosolid drug dispersion.,, 2012, 101,, 4191-4200,[http:\/\/dx.doi.org\/10.1002\/jps.23278]. [PMID: 22864998].","journal-title":"J Pharm Sci"},{"key":"ref=256","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/1120009X.2015.1105624","volume":"28","author":"Alipour S.","year":"2016","unstructured":"Alipour S, Montaseri H, Khalili A, Tafaghodi M. J Chemother, Non-invasive endotracheal delivery of paclitaxel-loaded alginate microparticles.,, 2016, 28,, 411-416,[http:\/\/dx.doi.org\/10.1080\/1120009X.2015.1105624]. [PMID: 27447444].","journal-title":"J Chemother"},{"key":"ref=257","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jconrel.2011.02.030","volume":"152","author":"Cruz L.","year":"2011","unstructured":"Cruz L, Fattal E, Tasso L. J Control Release, Formulation and  evaluation of sodium alendronate spray-dried microparticles intended for lung delivery.,, 2011, 152,, 370-375,[http:\/\/dx.doi.org\/10.1016\/j.jconrel.2011.02.030]. [PMID: 21396412].","journal-title":"J Control Release"},{"key":"ref=258","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3109\/03639045.2013.829486","volume":"40","author":"Piccirilli G.N.","year":"2014","unstructured":"Piccirilli GN, Garc\u00eda A, Leonardi D. Drug Dev Ind Pharm, Chitosan microparticles: influence of the gelation process on the release profile and oral bioavailability of albendazole, a class II compound.,, 2014, 40,, 1476-1482,[http:\/\/dx.doi.org\/10.3109\/03639045.2013.829486]. [PMID: 23971494].","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=259","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1007\/s11095-014-1382-7","volume":"31","author":"Zhong M.","year":"2014","unstructured":"Zhong M, Feng Y, Liao H. Pharm Res, Azithromycin cationic non-lecithoid nano\/microparticles improve bioavailability and targeting efficiency.,, 2014, 31,, 2857-2867,[http:\/\/dx.doi.org\/10.1007\/s11095-014-1382-7]. [PMID: 25208873].","journal-title":"Pharm Res"},{"key":"ref=260","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/10717544.2010.520353","volume":"18","author":"Gao Y.","year":"2011","unstructured":"Gao Y, Li Z, Sun M. Drug Deliv, Preparation and characterization of intravenously injectable curcumin nanosuspension.,, 2011, 18,, 131-142,[http:\/\/dx.doi.org\/10.3109\/10717544.2010.520353]. [PMID: 20939679].","journal-title":"Drug Deliv"},{"key":"ref=261","first-page":"295","volume":"3","author":"Junghanns J-U.A.","year":"2008","unstructured":"Junghanns J-UA, M\u00fcller RH. Int J Nanomedicine, Nanocrystal technology, drug delivery and clinical applications.,, 2008, 3,, 295-309,[PMID: 18990939].","journal-title":"Int J Nanomedicine"},{"key":"ref=262","author":"Diallo O","year":"2017","unstructured":"Diallo O, Philip M, Talwar N. Int J Nanomedicine, . Orally Disintegrating Tablet of\nNabilone Comprising Mannitol-Based Granules.WO2015131269A1,,, 2017, 3,, 295-,"},{"key":"ref=263","author":"Till M.C.","year":"2005","unstructured":"Till MC, Simkin MM, Maebius S. Nanotech meets the FDA: a success story about the first nanoparticulate drugs approved by the FDA, ,, 2005, 3,, 295-,","journal-title":"Nanotech meets the FDA: a success story about the first nanoparticulate drugs approved by the FDA"},{"key":"ref=264","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/157341307780619251","volume":"3","author":"Kesisoglou F.","year":"2007","unstructured":"Kesisoglou F, Panmai S, Wu Y. Curr Nanosci, Application of nanoparticles in oral delivery of immediate release formulations.,, 2007, 3,, 183-190,[http:\/\/dx.doi.org\/10.2174\/157341307780619251].","journal-title":"Curr Nanosci"},{"key":"ref=265","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2012.07.055","volume":"438","author":"Hu X.","year":"2012","unstructured":"Hu X, Lin C, Chen D. Int J Pharm, Sirolimus solid self-microemulsifying pellets: formulation development, characterization and bioavailability evaluation.,, 2012, 438,, 123-133,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2012.07.055]. [PMID: 22850296].","journal-title":"Int J Pharm"},{"key":"ref=266","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1002\/1521-3773(20011203)40:23<4330::AID-ANIE4330>3.0.CO;2-W","volume":"40","author":"Horn D.","year":"2001","unstructured":"Horn D, Rieger J. Angew Chem Int Ed Engl, Organic nanoparticles in the aqueous phase-theory, experiment, and use.,, 2001, 40,, 4330-4361,[http:\/\/dx.doi.org\/10.1002\/1521-3773(20011203)40:23<4330:AID-ANIE4330>3.0.CO;2-W]. [PMID: 12404417].","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=267","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jbiotec.2004.06.007","volume":"113","author":"Muller R.H.","year":"2004","unstructured":"Muller RH, Keck CM. J Biotechnol, Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.,, 2004, 113,, 151-170,[http:\/\/dx.doi.org\/10.1016\/j.jbiotec.2004.06.007]. [PMID: 15380654].","journal-title":"J Biotechnol"},{"key":"ref=268","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0192623307310946","volume":"36","author":"Merisko-Liversidge E.M.","year":"2008","unstructured":"Merisko-Liversidge EM, Liversidge GG. Toxicol Pathol, Drug nanoparticles: formulating poorly water-soluble compounds.,, 2008, 36,, 43-48,[http:\/\/dx.doi.org\/10.1177\/0192623307310946]. [PMID: 18337220].","journal-title":"Toxicol Pathol"},{"key":"ref=269","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1461-5347(99)00203-5","volume":"2","author":"Liu M.","year":"1999","unstructured":"Liu M, Fr\u00e9chet JM. Pharm Sci Technol Today, Designing dendrimers for drug delivery.,, 1999, 2,, 393-401,[http:\/\/dx.doi.org\/10.1016\/S1461-5347(99)00203-5]. [PMID: 10498919].","journal-title":"Pharm Sci Technol Today"},{"key":"ref=270","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejpb.2006.11.009","volume":"65","author":"Letchford K.","year":"2007","unstructured":"Letchford K, Burt H. Eur J Pharm Biopharm, A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes.,, 2007, 65,, 259-269,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2006.11.009]. [PMID: 17196803].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=271","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","volume":"11","author":"Pouton C.W.","year":"2000","unstructured":"Pouton CW. Eur J Pharm Sci, Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u2018self-microemulsifying\u2019 drug delivery systems.,, 2000, 11,, S93-S98,[http:\/\/dx.doi.org\/10.1016\/S0928-0987(00)00167-6]. [PMID: 11033431].","journal-title":"Eur J Pharm Sci"},{"key":"ref=272","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0378-5173(95)00122-Y","volume":"125","author":"Liversidge G.G.","year":"1995","unstructured":"Liversidge GG, Cundy KC. Int J Pharm, Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs.,, 1995, 125,, 91-97,[http:\/\/dx.doi.org\/10.1016\/0378-5173(95)00122-Y].","journal-title":"Int J Pharm"},{"key":"ref=273","author":"M\u00fcller R.H.","year":"1998","unstructured":"M\u00fcller RH, Benita S, B\u00f6hm BH. Emulsions and nanosuspensions for the formulation of poorly soluble drugs, ,, 1998, 125,, 91-,","journal-title":"Emulsions and nanosuspensions for the formulation of poorly soluble drugs"},{"key":"ref=274","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1021\/ja02086a003","volume":"19","author":"Noyes A.A.","year":"1897","unstructured":"Noyes AA, Whitney WR. J Am Chem Soc, The rate of solution of solid substances in their own solutions.,, 1897, 19,, 930-934,[http:\/\/dx.doi.org\/10.1021\/ja02086a003].","journal-title":"J Am Chem Soc"},{"key":"ref=275","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0378-5173(92)90162-U","volume":"84","author":"Jani P.","year":"1992","unstructured":"Jani P, Florence A, McCarthy D. Int J Pharm, Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat.,, 1992, 84,, 245-252,[http:\/\/dx.doi.org\/10.1016\/0378-5173(92)90162-U].","journal-title":"Int J Pharm"},{"key":"ref=276","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0378-5173(95)04353-5","volume":"132","author":"Hillery A.M.","year":"1996","unstructured":"Hillery AM, Florence AT. Int J Pharm, The effect of adsorbed poloxamer 188 and 407 surfactants on the intestinal uptake of 60-nm polystyrene particles after oral administration in the rat.,, 1996, 132,, 123-130,[http:\/\/dx.doi.org\/10.1016\/0378-5173(95)04353-5].","journal-title":"Int J Pharm"},{"key":"ref=277","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2004.08.001","volume":"285","author":"Wu Y.","year":"2004","unstructured":"Wu Y, Loper A, Landis E. Int J Pharm, The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.,, 2004, 285,, 135-146,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2004.08.001]. [PMID: 15488686].","journal-title":"Int J Pharm"},{"key":"ref=278","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1081\/DDC-52182","volume":"31","author":"Langguth P.","year":"2005","unstructured":"Langguth P, Hanafy A, Frenzel D. Drug Dev Ind Pharm, Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound.,, 2005, 31,, 319-329,[http:\/\/dx.doi.org\/10.1081\/DDC-52182]. [PMID: 15830727].","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=279","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejpb.2012.01.002","volume":"81","author":"De Zordi N.","year":"2012","unstructured":"De Zordi N, Moneghini M, Kikic I. Eur J Pharm Biopharm, Applications of supercritical fluids to enhance the dissolution behaviors of Furosemide by generation of microparticles and solid dispersions.,, 2012, 81,, 131-141,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2012.01.002]. [PMID: 22266263].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=280","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3109\/03639045.2013.838581","volume":"40","author":"Imperiale J.C.","year":"2014","unstructured":"Imperiale JC, Bevilacqua G, Rosa Pde T, Sosnik A. Drug Dev Ind Pharm, Production of pure indinavir free base nanoparticles by a supercritical anti-solvent (SAS) method.,, 2014, 40,, 1607-1615,[http:\/\/dx.doi.org\/10.3109\/03639045.2013.838581]. [PMID: 24050705].","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=281","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1016\/j.ces.2010.04.001","volume":"65","author":"Beck C.","year":"2010","unstructured":"Beck C, Dalvi SV, Dave RN. Chem Eng Sci, Controlled liquid antisolvent precipitation using a rapid mixing device.,, 2010, 65,, 5669-5675,[http:\/\/dx.doi.org\/10.1016\/j.ces.2010.04.001].","journal-title":"Chem Eng Sci"},{"key":"ref=282","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1115\/1.1811117","volume":"126","author":"Su J-C.","year":"2004","unstructured":"Su J-C, Liang SY, Liu WL, Jan TC. J Manuf Sci Eng, Ceramic micro\/nanoparticle size evolution in wet grinding in stirred ball mill.,, 2004, 126,, 779-786,[http:\/\/dx.doi.org\/10.1115\/1.1811117].","journal-title":"J Manuf Sci Eng"},{"key":"ref=283","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cep.2004.02.018","volume":"44","author":"Peukert W.","year":"2005","unstructured":"Peukert W, Schwarzer H-C, Stenger F. Chemical Engineering and Processing: Process Intensification, Control of aggregation in production and handling of nanoparticles.,, 2005, 44,, 245-252,[http:\/\/dx.doi.org\/10.1016\/j.cep.2004.02.018].","journal-title":"Chemical Engineering and Processing: Process Intensification"},{"key":"ref=284","author":"Muller R","year":"2000","unstructured":"Muller R, Bohm B, Grau J. Nanosuspensions: a formulation approach for poorly soluble and poorly bioavailable drugs, ,, 2000, 44,, 245-,","journal-title":"Nanosuspensions: a formulation approach for poorly soluble and poorly bioavailable drugs"},{"key":"ref=285","author":"Liversidge GG","year":"1992","unstructured":"Liversidge GG, Cundy KC, Bishop JF, Czekai DA. Nanosuspensions: a formulation approach for poorly soluble and poorly bioavailable drugs, Surface modified\ndrug nanoparticles. US5145684A, ,, 1992, 44,, 245-,"},{"key":"ref=286","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1002\/jps.10471","volume":"92","author":"Lee J.","year":"2003","unstructured":"Lee J. J Pharm Sci, Drug nano- and microparticles processed into solid dosage forms: physical properties.,, 2003, 92,, 2057-2068,[http:\/\/dx.doi.org\/10.1002\/jps.10471]. [PMID: 14502544].","journal-title":"J Pharm Sci"},{"key":"ref=287","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejps.2008.06.009","volume":"35","author":"Van Eerdenbrugh B.","year":"2008","unstructured":"Van Eerdenbrugh B, Froyen L, Van Humbeeck J, Martens JA, Augustijns P, Van den Mooter G. Eur J Pharm Sci, Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion.,, 2008, 35,, 127-135,[http:\/\/dx.doi.org\/10.1016\/j.ejps.2008.06.009]. [PMID: 18644441].","journal-title":"Eur J Pharm Sci"},{"key":"ref=288","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3109\/03639045.2010.551775","volume":"37","author":"Bhakay A.","year":"2011","unstructured":"Bhakay A, Merwade M, Bilgili E, Dave RN. Drug Dev Ind Pharm, Novel aspects of wet milling for the production of microsuspensions and nanosuspensions of poorly water-soluble drugs.,, 2011, 37,, 963-976,[http:\/\/dx.doi.org\/10.3109\/03639045.2010.551775]. [PMID: 21323486].","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=289","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejpb.2011.12.015","volume":"81","author":"Salazar J.","year":"2012","unstructured":"Salazar J, Ghanem A, M\u00fcller RH, M\u00f6schwitzer JP. Eur J Pharm Biopharm, Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches.,, 2012, 81,, 82-90,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2011.12.015]. [PMID: 22233547].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=290","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","volume":"59","author":"Kesisoglou F.","year":"2007","unstructured":"Kesisoglou F, Panmai S, Wu Y. Adv Drug Deliv Rev, Nanosizing--oral formulation development and biopharmaceutical evaluation.,, 2007, 59,, 631-644,[http:\/\/dx.doi.org\/10.1016\/j.addr.2007.05.003]. [PMID: 17601629].","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=291","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/pharmaceutics8020017","volume":"8","author":"Li M.","year":"2016","unstructured":"Li M, Azad M, Dav\u00e9 R, Bilgili E. Pharmaceutics, Nanomilling of drugs for bioavailability enhancement: a holistic formulation-process perspective.,, 2016, 8,, 17-,[http:\/\/dx.doi.org\/10.3390\/pharmaceutics8020017]. [PMID: 27213434].","journal-title":"Pharmaceutics"},{"key":"ref=292","author":"Bruno JA","year":"1996","unstructured":"Bruno JA, Doty BD, Gustow E, Illig KJ, Rajagopalan N, Sarpotdar P. Pharmaceutics, P. Method of grinding pharmaceutical substances. US5518187A,,, 1996, 8,, 17-,"},{"key":"ref=293","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ces.2004.12.057","volume":"61","author":"Sommer M.","year":"2006","unstructured":"Sommer M, Stenger F, Peukert W, Wagner N. Chem Eng Sci, Agglomeration and breakage of nanoparticles in stirred media mills-a comparison of different methods and models.,, 2006, 61,, 135-148,[http:\/\/dx.doi.org\/10.1016\/j.ces.2004.12.057].","journal-title":"Chem Eng Sci"},{"key":"ref=294","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.powtec.2009.05.007","volume":"195","author":"Knieke C.","year":"2009","unstructured":"Knieke C, Sommer M, Peukert W. Powder Technol, Identifying the apparent and true grinding limit.,, 2009, 195,, 25-30,[http:\/\/dx.doi.org\/10.1016\/j.powtec.2009.05.007].","journal-title":"Powder Technol"},{"key":"ref=295","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/pharmaceutics10030086","volume":"10","author":"Bhakay A.","year":"2018","unstructured":"Bhakay A, Rahman M, Dave RN, Bilgili E. Pharmaceutics, Bioavailability Enhancement of Poorly Water-Soluble Drugs  Nanocomposites: FormulationProcessing Aspects and Challenges.,, 2018, 10,, 86-,[http:\/\/dx.doi.org\/10.3390\/pharmaceutics10030086]. [PMID: 29986543].","journal-title":"Pharmaceutics"},{"key":"ref=296","doi-asserted-by":"crossref","DOI":"10.1201\/9780203492918","author":"Kim C-j.","year":"2004","unstructured":"Kim C-j. Advanced pharmaceutics: physicochemical principles, ,, 2004, 10,, 86-,[http:\/\/dx.doi.org\/10.1201\/9780203492918]","journal-title":"Advanced pharmaceutics: physicochemical principles"},{"key":"ref=297","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ejps.2012.12.026","volume":"48","author":"Zhang J.","year":"2013","unstructured":"Zhang J, Huang Y, Liu D, Gao Y, Qian S. Eur J Pharm Sci, Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement.,, 2013, 48,, 740-747,[http:\/\/dx.doi.org\/10.1016\/j.ejps.2012.12.026]. [PMID: 23305994].","journal-title":"Eur J Pharm Sci"},{"key":"ref=298","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejpb.2013.12.005","volume":"87","author":"Chen L.","year":"2014","unstructured":"Chen L, Wang Y, Zhang J. Eur J Pharm Biopharm, Bexarotene nanocrystal-Oral and parenteral formulation development, characterization and pharmacokinetic evaluation.,, 2014, 87,, 160-169,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2013.12.005]. [PMID: 24333772].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=299","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.2147\/IJN.S87143","volume":"10","author":"Liu D.","year":"2015","unstructured":"Liu D, Pan H, He F. Int J Nanomedicine, Effect of particle size on oral absorption of carvedilol nanosuspensions:  and  evaluation.,, 2015, 10,, 6425-6434,[http:\/\/dx.doi.org\/10.2147\/IJN.S87143]. [PMID: 26508852].","journal-title":"Int J Nanomedicine"},{"key":"ref=300","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ijpharm.2014.12.003","volume":"478","author":"Ahuja B.K.","year":"2015","unstructured":"Ahuja BK, Jena SK, Paidi SK, Bagri S, Suresh S. Int J Pharm, Formulation, optimization and  evaluation of febuxostat nanosuspension.,, 2015, 478,, 540-552,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2014.12.003]. [PMID: 25490182].","journal-title":"Int J Pharm"},{"key":"ref=301","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijpharm.2012.04.025","volume":"430","author":"Quan P.","year":"2012","unstructured":"Quan P, Shi K, Piao H. Int J Pharm, A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability.,, 2012, 430,, 366-371,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2012.04.025]. [PMID: 22531846].","journal-title":"Int J Pharm"},{"key":"ref=302","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ejpb.2013.09.003","volume":"85","author":"Onoue S.","year":"2013","unstructured":"Onoue S, Yamamoto K, Kawabata Y, Yamada S. Eur J Pharm Biopharm, \n                        \/ characterization of nanocrystalline formulation of tranilast with improved dissolution and hepatoprotective properties.,, 2013, 85,, 952-957,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2013.09.003]. [PMID: 24055688].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=303","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0378-5173(02)00114-X","volume":"240","author":"Vergote G.J.","year":"2002","unstructured":"Vergote GJ, Vervaet C, Van Driessche I. Int J Pharm, \n                         evaluation of matrix pellets containing nanocrystalline ketoprofen.,, 2002, 240,, 79-84,[http:\/\/dx.doi.org\/10.1016\/S0378-5173(02)00114-X]. [PMID: 12062503].","journal-title":"Int J Pharm"},{"key":"ref=304","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.addr.2007.04.005","volume":"59","author":"Hanafy A.","year":"2007","unstructured":"Hanafy A, Spahn-Langguth H, Vergnault G. Adv Drug Deliv Rev, Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug.,, 2007, 59,, 419-426,[http:\/\/dx.doi.org\/10.1016\/j.addr.2007.04.005]. [PMID: 17566595].","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=305","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijpharm.2006.02.045","volume":"317","author":"M\u00fcller R.H.","year":"2006","unstructured":"M\u00fcller RH, Runge S, Ravelli V, Mehnert W, Th\u00fcnemann AF, Souto EB. Int J Pharm, Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.,, 2006, 317,, 82-89,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2006.02.045]. [PMID: 16580159].","journal-title":"Int J Pharm"},{"key":"ref=306","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijpharm.2011.04.034","volume":"413","author":"Mou D.","year":"2011","unstructured":"Mou D, Chen H, Wan J, Xu H, Yang X. Int J Pharm, Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.,, 2011, 413,, 237-244,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2011.04.034]. [PMID: 21540090].","journal-title":"Int J Pharm"},{"key":"ref=307","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1021\/mp300688t","volume":"10","author":"Li Y.","year":"2013","unstructured":"Li Y, Sun S, Chang Q. Mol Pharm, A strategy for the improvement of the bioavailability and antiosteoporosis activity of BCS IV flavonoid glycosides through the formulation of their lipophilic aglycone into nanocrystals.,, 2013, 10,, 2534-2542,[http:\/\/dx.doi.org\/10.1021\/mp300688t]. [PMID: 23659498].","journal-title":"Mol Pharm"},{"key":"ref=308","doi-asserted-by":"crossref","first-page":"196","DOI":"10.18433\/J3PW2W","volume":"14","author":"Miao X.","year":"2011","unstructured":"Miao X, Sun C, Jiang T, Zheng L, Wang T, Wang S. J Pharm Pharm Sci, Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.,, 2011, 14,, 196-214,[http:\/\/dx.doi.org\/10.18433\/J3PW2W]. [PMID: 21733409].","journal-title":"J Pharm Pharm Sci"},{"key":"ref=309","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijpharm.2007.12.016","volume":"355","author":"Gao L.","year":"2008","unstructured":"Gao L, Zhang D, Chen M. Int J Pharm, Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions.,, 2008, 355,, 321-327,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2007.12.016]. [PMID: 18242896].","journal-title":"Int J Pharm"},{"key":"ref=310","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2008.09.022","volume":"367","author":"Ganta S.","year":"2009","unstructured":"Ganta S, Paxton JW, Baguley BC, Garg S. Int J Pharm, Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery.,, 2009, 367,, 179-186,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2008.09.022]. [PMID: 18848873].","journal-title":"Int J Pharm"},{"key":"ref=311","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1208\/s12249-012-9896-y","volume":"14","author":"Saindane N.S.","year":"2013","unstructured":"Saindane NS, Pagar KP, Vavia PR. AAPS PharmSciTech, Nanosuspension based  gelling nasal spray of carvedilol: development,  and  characterization.,, 2013, 14,, 189-199,[http:\/\/dx.doi.org\/10.1208\/s12249-012-9896-y]. [PMID: 23255198].","journal-title":"AAPS PharmSciTech"},{"key":"ref=312","first-page":"204","volume":"34","author":"Clement M.","year":"1992","unstructured":"Clement M, Pugh W, Parikh I. Pharmacologist, Tissue distribution and plasma clearance of a novel microcrystalline-coated flurbiprofen formulation.,, 1992, 34,, 204-,","journal-title":"Pharmacologist"},{"key":"ref=313","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.45.6.1771-1779.2001","volume":"45","author":"Sch\u00f6ler N.","year":"2001","unstructured":"Sch\u00f6ler N, Krause K, Kayser O. Antimicrob Agents Chemother, Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis.,, 2001, 45,, 1771-1779,[http:\/\/dx.doi.org\/10.1128\/AAC.45.6.1771-1779.2001]. [PMID: 11353624].","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=314","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2010.10.007","volume":"149","author":"Ali H.S.","year":"2011","unstructured":"Ali HS, York P, Ali AM, Blagden N. J Control Release, Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling.,, 2011, 149,, 175-181,[http:\/\/dx.doi.org\/10.1016\/j.jconrel.2010.10.007]. [PMID: 20946923].","journal-title":"J Control Release"},{"key":"ref=315","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijpharm.2011.04.023","volume":"413","author":"Wang L.","year":"2011","unstructured":"Wang L, Liu Z, Liu D, Liu C, Juan Z, Zhang N. Int J Pharm, Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity.,, 2011, 413,, 194-201,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2011.04.023]. [PMID: 21540085].","journal-title":"Int J Pharm"},{"key":"ref=316","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2011.05.075","volume":"415","author":"Zhang H.","year":"2011","unstructured":"Zhang H, Hollis CP, Zhang Q, Li T. Int J Pharm, Preparation and antitumor study of camptothecin nanocrystals.,, 2011, 415,, 293-300,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2011.05.075]. [PMID: 21679755].","journal-title":"Int J Pharm"},{"key":"ref=317","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3109\/10837450.2012.663391","volume":"18","author":"Pokharkar V.B.","year":"2013","unstructured":"Pokharkar VB, Malhi T, Mandpe L. Pharm Dev Technol, Bicalutamide nanocrystals with improved oral bioavailability:  and  evaluation.,, 2013, 18,, 660-666,[http:\/\/dx.doi.org\/10.3109\/10837450.2012.663391]. [PMID: 22394215].","journal-title":"Pharm Dev Technol"},{"key":"ref=318","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijpharm.2012.05.002","volume":"433","author":"Hao L.","year":"2012","unstructured":"Hao L, Wang X, Zhang D. Int J Pharm, Studies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystals.,, 2012, 433,, 157-164,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2012.05.002]. [PMID: 22579996].","journal-title":"Int J Pharm"},{"key":"ref=319","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ijpharm.2012.10.021","volume":"441","author":"Wang Y.","year":"2013","unstructured":"Wang Y, Ma Y, Zheng Y. Int J Pharm, \n                         and  anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity.,, 2013, 441,, 728-735,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2012.10.021]. [PMID: 23089583].","journal-title":"Int J Pharm"},{"key":"ref=320","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejps.2012.09.015","volume":"47","author":"Talekar M.","year":"2012","unstructured":"Talekar M, Kendall J, Denny W, Jamieson S, Garg S. Eur J Pharm Sci, Development and evaluation of PIK75 nanosuspension, a phosphatidylinositol-3-kinase inhibitor.,, 2012, 47,, 824-833,[http:\/\/dx.doi.org\/10.1016\/j.ejps.2012.09.015]. [PMID: 23069617].","journal-title":"Eur J Pharm Sci"},{"key":"ref=321","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1208\/s12249-013-0005-7","volume":"14","author":"Huang Y.","year":"2013","unstructured":"Huang Y, Luo X, You X, Xia Y, Song X, Yu L. AAPS PharmSciTech, The preparation and evaluation of water-soluble SKLB610 nanosuspensions with improved bioavailability.,, 2013, 14,, 1236-1243,[http:\/\/dx.doi.org\/10.1208\/s12249-013-0005-7]. [PMID: 23934433].","journal-title":"AAPS PharmSciTech"},{"key":"ref=322","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijpharm.2011.09.041","volume":"421","author":"Shegokar R.","year":"2011","unstructured":"Shegokar R, Singh KK. Int J Pharm, Surface modified nevirapine nanosuspensions for viral reservoir targeting:  and  evaluation.,, 2011, 421,, 341-352,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2011.09.041]. [PMID: 21986114].","journal-title":"Int J Pharm"},{"key":"ref=323","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejpb.2009.03.006","volume":"72","author":"Baert L.","year":"2009","unstructured":"Baert L, van \u2019t Klooster G, Dries W. Eur J Pharm Biopharm, Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment.,, 2009, 72,, 502-508,[http:\/\/dx.doi.org\/10.1016\/j.ejpb.2009.03.006]. [PMID: 19328850].","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=324","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/03639045.2012.746362","volume":"40","author":"Patel G.V.","year":"2014","unstructured":"Patel GV, Patel VB, Pathak A, Rajput SJ. Drug Dev Ind Pharm, Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization,  and  evaluation.,, 2014, 40,, 80-91,[http:\/\/dx.doi.org\/10.3109\/03639045.2012.746362]. [PMID: 23323843].","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=325","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijpharm.2012.11.039","volume":"441","author":"Guo J.J.","year":"2013","unstructured":"Guo JJ, Yue P-F, Lv JL. Int J Pharm, Development and  evaluation of novel herpetrione nanosuspension.,, 2013, 441,, 227-233,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2012.11.039]. [PMID: 23220096].","journal-title":"Int J Pharm"},{"key":"ref=326","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/10611861003733995","volume":"19","author":"Shubar H.M.","year":"2011","unstructured":"Shubar HM, Lachenmaier S, Heimesaat MM. J Drug Target, SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood-brain barriers.,, 2011, 19,, 114-124,[http:\/\/dx.doi.org\/10.3109\/10611861003733995]. [PMID: 20367080].","journal-title":"J Drug Target"},{"key":"ref=327","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1208\/s12249-012-9860-x","volume":"13","author":"Bajaj A.","year":"2012","unstructured":"Bajaj A, Rao MR, Pardeshi A, Sali D. AAPS PharmSciTech, Nanocrystallization by evaporative antisolvent technique for solubility and bioavailability enhancement of telmisartan.,, 2012, 13,, 1331-1340,[http:\/\/dx.doi.org\/10.1208\/s12249-012-9860-x]. [PMID: 23054986].","journal-title":"AAPS PharmSciTech"},{"key":"ref=328","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3797\/scipharm.1103-17","volume":"79","author":"Detroja C.","year":"2011","unstructured":"Detroja C, Chavhan S, Sawant K. Sci Pharm, Enhanced antihypertensive activity of candesartan cilexetil nanosuspension: formulation, characterization and pharmacodynamic study.,, 2011, 79,, 635-651,[http:\/\/dx.doi.org\/10.3797\/scipharm.1103-17]. [PMID: 21886909].","journal-title":"Sci Pharm"},{"key":"ref=329","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4103\/0975-7406.84459","volume":"3","author":"Thakkar H.P.","year":"2011","unstructured":"Thakkar HP, Patel BV, Thakkar SP. J Pharm Bioallied Sci, Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement.,, 2011, 3,, 426-434,[http:\/\/dx.doi.org\/10.4103\/0975-7406.84459]. [PMID: 21966165].","journal-title":"J Pharm Bioallied Sci"},{"key":"ref=330","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ejps.2013.04.003","volume":"49","author":"Salazar J.","year":"2013","unstructured":"Salazar J, M\u00fcller RH, M\u00f6schwitzer JP. Eur J Pharm Sci, Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.,, 2013, 49,, 565-577,[http:\/\/dx.doi.org\/10.1016\/j.ejps.2013.04.003]. [PMID: 23587645].","journal-title":"Eur J Pharm Sci"},{"key":"ref=331","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.nano.2009.12.004","volume":"6","author":"Lemke A.","year":"2010","unstructured":"Lemke A, Kiderlen AF, Petri B, Kayser O. Nanomedicine (Lond), Delivery of amphotericin B nanosuspensions to the brain and determination of activity against Balamuthia mandrillaris amebas.,, 2010, 6,, 597-603,[http:\/\/dx.doi.org\/10.1016\/j.nano.2009.12.004]. [PMID: 20060497].","journal-title":"Nanomedicine (Lond)"},{"key":"ref=332","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijpharm.2013.06.039","volume":"454","author":"Freag M.S.","year":"2013","unstructured":"Freag MS, Elnaggar YS, Abdallah OY. Int J Pharm, Development of novel polymer-stabilized diosmin nanosuspensions:  appraisal and  permeation.,, 2013, 454,, 462-471,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2013.06.039]. [PMID: 23830765].","journal-title":"Int J Pharm"},{"key":"ref=333","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/2229-516X.81972","volume":"1","author":"Randhawa G.K.","year":"2011","unstructured":"Randhawa GK, Kullar JS. Int J Appl Basic Med Res, Rajkumar. Bioenhancers from mother nature and their applicability in modern medicine.,, 2011, 1,, 5-10,[http:\/\/dx.doi.org\/10.4103\/2229-516X.81972]. [PMID: 23776764].","journal-title":"Int J Appl Basic Med Res"},{"key":"ref=334","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fitote.2014.05.005","volume":"97","author":"Ajazuddin Alexander A","year":"2014","unstructured":"Ajazuddin Alexander A. Fitoterapia, Qureshi A, et al Role of herbal bioactives as a potential bioavailability enhancer for Active Pharmaceutical Ingredients.,, 2014, 97,, 1-14,[http:\/\/dx.doi.org\/10.1016\/j.fitote.2014.05.005]. [PMID: 24862064].","journal-title":"Fitoterapia"},{"key":"ref=335","doi-asserted-by":"crossref","first-page":"637953","DOI":"10.1100\/2012\/637953","volume":"2012","author":"Dudhatra G.B.","year":"2012","unstructured":"Dudhatra GB, Mody SK, Awale MM. Sci World J, A comprehensive review on pharmacotherapeutics of herbal bioenhancers.,, 2012, 2012,, 637953-,[http:\/\/dx.doi.org\/10.1100\/2012\/637953].","journal-title":"Sci World J"},{"key":"ref=336","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1517\/17425255.2011.570332","volume":"7","author":"Han H-K.","year":"2011","unstructured":"Han H-K. Expert Opin Drug Metab Toxicol, The effects of black pepper on the intestinal absorption and hepatic metabolism of drugs.,, 2011, 7,, 721-729,[http:\/\/dx.doi.org\/10.1517\/17425255.2011.570332]. [PMID: 21434835].","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref=337","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1078\/0944-7113-00114","volume":"9","author":"Khajuria A.","year":"2002","unstructured":"Khajuria A, Thusu N, Zutshi U. Phytomedicine, Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: influence on brush border membrane fluidity, ultrastructure and enzyme kinetics.,, 2002, 9,, 224-231,[http:\/\/dx.doi.org\/10.1078\/0944-7113-00114]. [PMID: 12046863].","journal-title":"Phytomedicine"},{"key":"ref=338","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0378-8741(81)90037-4","volume":"4","author":"Atal C.K.","year":"1981","unstructured":"Atal CK, Zutshi U, Rao PG. J Ethnopharmacol, Scientific evidence on the role of Ayurvedic herbals on bioavailability of drugs.,, 1981, 4,, 229-232,[http:\/\/dx.doi.org\/10.1016\/0378-8741(81)90037-4]. [PMID: 7311598].","journal-title":"J Ethnopharmacol"},{"key":"ref=339","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/2229-3485.128027","volume":"5","author":"Choudhary N.","year":"2014","unstructured":"Choudhary N, Khajuria V, Gillani ZH, Tandon VR, Arora E. Perspect Clin Res, Effect of Carum carvi, a herbal bioenhancer on pharmacokinetics of antitubercular drugs: A study in healthy human volunteers.,, 2014, 5,, 80-84,[http:\/\/dx.doi.org\/10.4103\/2229-3485.128027]. [PMID: 24741485].","journal-title":"Perspect Clin Res"},{"key":"ref=340","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijpharm.2007.01.002","volume":"337","author":"Li X.","year":"2007","unstructured":"Li X, Choi J-S. Int J Pharm, Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats.,, 2007, 337,, 188-193,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2007.01.002]. [PMID: 17267149].","journal-title":"Int J Pharm"},{"key":"ref=341","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/bdd.523","volume":"27","author":"Lim S.C.","year":"2006","unstructured":"Lim SC, Choi JS. Biopharm Drug Dispos, Effects of naringin on the pharmacokinetics of intravenous paclitaxel in rats.,, 2006, 27,, 443-447,[http:\/\/dx.doi.org\/10.1002\/bdd.523]. [PMID: 17009338].","journal-title":"Biopharm Drug Dispos"},{"key":"ref=342","doi-asserted-by":"crossref","first-page":"1983S","DOI":"10.1093\/jn\/133.6.1983S","volume":"133","author":"Kurzer M.S.","year":"2003","unstructured":"Kurzer MS. J Nutr, Phytoestrogen supplement use by women.,, 2003, 133,, 1983S-1986S,[http:\/\/dx.doi.org\/10.1093\/jn\/133.6.1983S]. [PMID: 12771350].","journal-title":"J Nutr"},{"key":"ref=343","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.94.5.2031","volume":"94","author":"Sparreboom A.","year":"1997","unstructured":"Sparreboom A, van Asperen J, Mayer U. Proc Natl Acad Sci USA, Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine.,, 1997, 94,, 2031-2035,[http:\/\/dx.doi.org\/10.1073\/pnas.94.5.2031]. [PMID: 9050899].","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=344","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1038\/sj.onc.1206938","volume":"22","author":"Doyle L.","year":"2003","unstructured":"Doyle L, Ross DD. Oncogene, Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).,, 2003, 22,, 7340-7358,[http:\/\/dx.doi.org\/10.1038\/sj.onc.1206938]. [PMID: 14576842].","journal-title":"Oncogene"},{"key":"ref=345","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ijc.21013","volume":"116","author":"Huisman M.T.","year":"2005","unstructured":"Huisman MT, Chhatta AA, van Tellingen O, Beijnen JH, Schinkel AH. Int J Cancer, MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid.,, 2005, 116,, 824-829,[http:\/\/dx.doi.org\/10.1002\/ijc.21013]. [PMID: 15849751].","journal-title":"Int J Cancer"},{"key":"ref=346","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.2042-7158.1995.tb03293.x","volume":"47","author":"Takeda S.","year":"1995","unstructured":"Takeda S, Isono T, Wakui Y. J Pharm Pharmacol, Absorption and excretion of paeoniflorin in rats.,, 1995, 47,, 1036-1040,[http:\/\/dx.doi.org\/10.1111\/j.2042-7158.1995.tb03293.x]. [PMID: 8932691].","journal-title":"J Pharm Pharmacol"},{"key":"ref=347","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jep.2005.01.052","volume":"99","author":"Liu Z.Q.","year":"2005","unstructured":"Liu ZQ, Zhou H, Liu L. J Ethnopharmacol, Influence of co-administrated sinomenine on pharmacokinetic fate of paeoniflorin in unrestrained conscious rats.,, 2005, 99,, 61-67,[http:\/\/dx.doi.org\/10.1016\/j.jep.2005.01.052]. [PMID: 15848021].","journal-title":"J Ethnopharmacol"},{"key":"ref=348","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jep.2005.08.020","volume":"103","author":"Chan K.","year":"2006","unstructured":"Chan K, Liu ZQ, Jiang ZH. J Ethnopharmacol, The effects of sinomenine on intestinal absorption of paeoniflorin by the everted rat gut sac model.,, 2006, 103,, 425-432,[http:\/\/dx.doi.org\/10.1016\/j.jep.2005.08.020]. [PMID: 16169700].","journal-title":"J Ethnopharmacol"},{"key":"ref=349","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ajcn\/74.4.418","volume":"74","author":"Nijveldt R.J.","year":"2001","unstructured":"Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. Am J Clin Nutr, Flavonoids: a review of probable mechanisms of action and potential applications.,, 2001, 74,, 418-425,[http:\/\/dx.doi.org\/10.1093\/ajcn\/74.4.418]. [PMID: 11566638].","journal-title":"Am J Clin Nutr"},{"key":"ref=350","first-page":"5002","volume":"49","author":"Yusa K.","year":"1989","unstructured":"Yusa K, Tsuruo T. Cancer Res, Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562\/ADM cells.,, 1989, 49,, 5002-5006,[PMID: 2569930].","journal-title":"Cancer Res"},{"key":"ref=351","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-5793(93)81540-G","volume":"324","author":"Saeki T.","year":"1993","unstructured":"Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T. FEBS Lett, P-glycoprotein-mediated transcellular transport of MDR-reversing agents.,, 1993, 324,, 99-102,[http:\/\/dx.doi.org\/10.1016\/0014-5793(93)81540-G]. [PMID: 8099333].","journal-title":"FEBS Lett"},{"key":"ref=352","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF00685655","volume":"34","author":"Scambia G.","year":"1994","unstructured":"Scambia G, Ranelletti FO, Panici PB. Cancer Chemother Pharmacol, Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target.,, 1994, 34,, 459-464,[http:\/\/dx.doi.org\/10.1007\/BF00685655]. [PMID: 7923555].","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=353","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0006-2952(96)00826-X","volume":"53","author":"Shapiro A.B.","year":"1997","unstructured":"Shapiro AB, Ling V. Biochem Pharmacol, Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein.,, 1997, 53,, 587-596,[http:\/\/dx.doi.org\/10.1016\/S0006-2952(96)00826-X]. [PMID: 9105411].","journal-title":"Biochem Pharmacol"},{"key":"ref=354","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.12.004","volume":"297","author":"Choi J-S.","year":"2005","unstructured":"Choi J-S, Li X. Int J Pharm, Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits.,, 2005, 297,, 1-8,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2004.12.004]. [PMID: 15907592].","journal-title":"Int J Pharm"},{"key":"ref=355","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.lfs.2003.06.044","volume":"74","author":"Wang Y-H.","year":"2004","unstructured":"Wang Y-H, Chao P-DL, Hsiu S-L, Wen K-C, Hou Y-C. Life Sci, Lethal quercetin-digoxin interaction in pigs.,, 2004, 74,, 1191-1197,[http:\/\/dx.doi.org\/10.1016\/j.lfs.2003.06.044]. [PMID: 14697403].","journal-title":"Life Sci"},{"key":"ref=356","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2004.12.029","volume":"294","author":"Imai T.","year":"2005","unstructured":"Imai T, Sakai M, Ohtake H, Azuma H, Otagiri M. Int J Pharm, Absorption-enhancing effect of glycyrrhizin induced in the presence of capric acid.,, 2005, 294,, 11-21,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2004.12.029]. [PMID: 15814227].","journal-title":"Int J Pharm"},{"key":"ref=357","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1211\/0022357991772051","volume":"51","author":"Sakai M.","year":"1999","unstructured":"Sakai M, Imai T, Ohtake H, Azuma H, Otagiri M. J Pharm Pharmacol, Simultaneous use of sodium deoxycholate and dipotassium glycyrrhizinate enhances the cellular transport of poorly absorbed compounds across Caco-2 cell monolayers.,, 1999, 51,, 27-33,[http:\/\/dx.doi.org\/10.1211\/0022357991772051]. [PMID: 10197414].","journal-title":"J Pharm Pharmacol"},{"key":"ref=358","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1515\/DMDI.2000.17.1-4.351","volume":"17","author":"Zhang H.","year":"2000","unstructured":"Zhang H, Wong CW, Coville PF, Wanwimolruk S. Drug Metabol Drug Interact, Effect of the grapefruit flavonoid naringin on pharmacokinetics of quinine in rats.,, 2000, 17,, 351-363,[http:\/\/dx.doi.org\/10.1515\/DMDI.2000.17.1-4.351]. [PMID: 11201303].","journal-title":"Drug Metabol Drug Interact"},{"key":"ref=359","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00126839-200708060-00006","volume":"8","author":"Kasibhatta R.","year":"2007","unstructured":"Kasibhatta R, Naidu MU. Drugs R D, Influence of piperine on the pharmacokinetics of nevirapine under fasting conditions: a randomised, crossover, placebo-controlled study.,, 2007, 8,, 383-391,[http:\/\/dx.doi.org\/10.2165\/00126839-200708060-00006]. [PMID: 17963429].","journal-title":"Drugs R D"},{"key":"ref=360","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/0975-7406.168036","volume":"7","author":"Parveen B.","year":"2015","unstructured":"Parveen B, Pillai KK, Tamboli ET, Ahmad S. J Pharm Bioallied Sci, Effect of piperine on pharmacokinetics of sodium valproate in plasma samples of rats using gas chromatography-mass spectrometry method.,, 2015, 7,, 317-320,[http:\/\/dx.doi.org\/10.4103\/0975-7406.168036]. [PMID: 26681892].","journal-title":"J Pharm Bioallied Sci"},{"key":"ref=361","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/0974-8490.171096","volume":"8","author":"Atal S.","year":"2016","unstructured":"Atal S, Atal S, Vyas S, Phadnis P. Pharmacognosy Res, Bio-enhancing effect of piperine with metformin on lowering blood glucose level in alloxan induced diabetic mice.,, 2016, 8,, 56-60,[http:\/\/dx.doi.org\/10.4103\/0974-8490.171096]. [PMID: 26941537].","journal-title":"Pharmacognosy Res"},{"key":"ref=362","first-page":"141","volume":"6","author":"Sayyah M.","year":"2002","unstructured":"Sayyah M, Peirovi A, Kamalinejad M. Iran Biomed J, Anti-nociceptive effect of the fruit essential oil of  in rat.,, 2002, 6,, 141-145,","journal-title":"Iran Biomed J"},{"key":"ref=363","author":"Qazi GN","year":"2006","unstructured":"Qazi GN, Bedi KL, Johri RK. Iran Biomed J, ,, 2006, 6,, 141-,"},{"key":"ref=364","author":"Khanuja S","year":"2007","unstructured":"Khanuja S, Arya J, Srivastava S. Iran Biomed J, ,, 2007, 6,, 141-,"},{"key":"ref=365","doi-asserted-by":"crossref","first-page":"58933","DOI":"10.1039\/C6RA09307H","volume":"6","author":"Shukla M.","year":"2016","unstructured":"Shukla M, Malik M, Jaiswal S. RSC Advances, A mechanistic investigation of the bioavailability enhancing potential of lysergol, a novel bioenhancer, using curcumin.,, 2016, 6,, 58933-58942,[http:\/\/dx.doi.org\/10.1039\/C6RA09307H].","journal-title":"RSC Advances"},{"key":"ref=366","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.phymed.2003.12.013","volume":"12","author":"Vinson J.A.","year":"2005","unstructured":"Vinson JA, Al Kharrat H, Andreoli L. Phytomedicine, Effect of Aloe vera preparations on the human bioavailability of vitamins C and E.,, 2005, 12,, 760-765,[http:\/\/dx.doi.org\/10.1016\/j.phymed.2003.12.013]. [PMID: 16323295].","journal-title":"Phytomedicine"},{"key":"ref=367","author":"Qazi G","year":"2003","unstructured":"Qazi G, Bedi K, Johri R. Phytomedicine, ,, 2003, 12,, 760-,"},{"key":"ref=368","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1055\/s-2006-947203","volume":"72","author":"Ogita A.","year":"2006","unstructured":"Ogita A, Fujita K, Taniguchi M, Tanaka T. Planta Med, Enhancement of the fungicidal activity of amphotericin B by allicin, an allyl-sulfur compound from garlic, against the yeast Saccharomyces cerevisiae as a model system.,, 2006, 72,, 1247-1250,[http:\/\/dx.doi.org\/10.1055\/s-2006-947203]. [PMID: 16902870].","journal-title":"Planta Med"},{"key":"ref=369","author":"Khanuja SPS","year":"2005","unstructured":"Khanuja SPS, Arya JS, Tiruppadiripuliyur RSK. Planta Med, ,, 2005, 72,, 1247-,"},{"key":"ref=370","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.drudis.2012.05.010","volume":"17","author":"Parhi P.","year":"2012","unstructured":"Parhi P, Mohanty C, Sahoo SK. Drug Discov Today, Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy.,, 2012, 17,, 1044-1052,[http:\/\/dx.doi.org\/10.1016\/j.drudis.2012.05.010]. [PMID: 22652342].","journal-title":"Drug Discov Today"},{"key":"ref=371","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1124\/jpet.102.034728","volume":"302","author":"Bhardwaj R.K.","year":"2002","unstructured":"Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF. J Pharmacol Exp Ther, Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3.,, 2002, 302,, 645-650,","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=372","first-page":"265","volume":"2","author":"Lai G-H.","year":"2003","unstructured":"Lai G-H, Zhang Z, Sirica AE. Mol Cancer Ther, Celecoxib acts in a cyclooxygenase-2-independent manner and in synergy with emodin to suppress rat cholangiocarcinoma growth  through a mechanism involving enhanced Akt inactivation and increased activation of caspases-9 and -3.,, 2003, 2,, 265-271,[PMID: 12657721].","journal-title":"Mol Cancer Ther"},{"key":"ref=373","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-5173(00)00445-2","volume":"202","author":"Veiga F.","year":"2000","unstructured":"Veiga F, Fernandes C, Teixeira F. Int J Pharm, Oral bioavailability and hypoglycaemic activity of tolbutamide\/cyclodextrin inclusion complexes.,, 2000, 202,, 165-171,[http:\/\/dx.doi.org\/10.1016\/S0378-5173(00)00445-2]. [PMID: 10915940].","journal-title":"Int J Pharm"},{"key":"ref=374","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","volume":"204","author":"Leslie E.M.","year":"2005","unstructured":"Leslie EM, Deeley RG, Cole SP. Toxicol Appl Pharmacol, Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.,, 2005, 204,, 216-237,[http:\/\/dx.doi.org\/10.1016\/j.taap.2004.10.012]. [PMID: 15845415].","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=375","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.biopha.2006.07.081","volume":"60","author":"Brand W.","year":"2006","unstructured":"Brand W, Schutte ME, Williamson G. Biomed Pharmacother, Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients.,, 2006, 60,, 508-519,[http:\/\/dx.doi.org\/10.1016\/j.biopha.2006.07.081]. [PMID: 16978825].","journal-title":"Biomed Pharmacother"},{"key":"ref=376","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jps.2600590502","volume":"59","author":"Gibaldi M.","year":"1970","unstructured":"Gibaldi M, Feldman S. J Pharm Sci, Mechanisms of surfactant effects on drug absorption.,, 1970, 59,, 579-589,[http:\/\/dx.doi.org\/10.1002\/jps.2600590502]. [PMID: 4911055].","journal-title":"J Pharm Sci"},{"key":"ref=377","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1021\/bc800076n","volume":"19","author":"Mi F-L.","year":"2008","unstructured":"Mi F-L, Wu Y-Y, Lin Y-H. Bioconjug Chem, Oral delivery of peptide drugs using nanoparticles self-assembled by poly(\u03b3-glutamic acid) and a chitosan derivative functionalized by trimethylation.,, 2008, 19,, 1248-1255,[http:\/\/dx.doi.org\/10.1021\/bc800076n]. [PMID: 18517235].","journal-title":"Bioconjug Chem"},{"key":"ref=378","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/00970002042006005","volume":"42","author":"Martinez M.N.","year":"2002","unstructured":"Martinez MN, Amidon GL. J Clin Pharmacol, A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals.,, 2002, 42,, 620-643,[http:\/\/dx.doi.org\/10.1177\/00970002042006005]. [PMID: 12043951].","journal-title":"J Clin Pharmacol"},{"key":"ref=379","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0169-409X(01)00151-X","volume":"50","author":"Porter C.J.","year":"2001","unstructured":"Porter CJ, Charman WN. Adv Drug Deliv Rev, Intestinal lymphatic drug transport: an update.,, 2001, 50,, 61-80,[http:\/\/dx.doi.org\/10.1016\/S0169-409X(01)00151-X]. [PMID: 11489334].","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=380","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1039\/c2fo10254d","volume":"3","author":"Wang P.","year":"2012","unstructured":"Wang P, Heber D, Henning SM. Food Funct, Quercetin increased bioavailability and decreased methylation of green tea polyphenols  and ,, 2012, 3,, 635-642,[http:\/\/dx.doi.org\/10.1039\/c2fo10254d]. [PMID: 22438067].","journal-title":"Food Funct"},{"key":"ref=381","doi-asserted-by":"crossref","first-page":"H93","DOI":"10.1111\/j.1750-3841.2010.01542.x","volume":"75","author":"Jin M.J.","year":"2010","unstructured":"Jin MJ, Han HK. J Food Sci, Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction.,, 2010, 75,, H93-H96,[http:\/\/dx.doi.org\/10.1111\/j.1750-3841.2010.01542.x]. [PMID: 20492299].","journal-title":"J Food Sci"},{"key":"ref=382","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jep.2009.02.001","volume":"122","author":"Nair P.K.","year":"2009","unstructured":"Nair PK, Melnick SJ, Wnuk SF, Rapp M, Escalon E, Ramachandran C. J Ethnopharmacol, Isolation and characterization of an anticancer catechol compound from Semecarpus anacardium.,, 2009, 122,, 450-456,[http:\/\/dx.doi.org\/10.1016\/j.jep.2009.02.001]. [PMID: 19429311].","journal-title":"J Ethnopharmacol"},{"key":"ref=383","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/ptr.2676","volume":"23","author":"Pattanaik S.","year":"2009","unstructured":"Pattanaik S, Hota D, Prabhakar S, Kharbanda P, Pandhi P. Phytother Res, Pharmacokinetic interaction of single dose of piperine with steady-state carbamazepine in epilepsy patients.,, 2009, 23,, 1281-1286,[http:\/\/dx.doi.org\/10.1002\/ptr.2676]. [PMID: 19283724].","journal-title":"Phytother Res"},{"key":"ref=384","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3109\/03639045.2012.707209","volume":"39","author":"Babu P.R.","year":"2013","unstructured":"Babu PR, Babu KN, Peter PL, Rajesh K, Babu PJ. Drug Dev Ind Pharm, Influence of quercetin on the pharmacokinetics of ranolazine in rats and  models.,, 2013, 39,, 873-879,[http:\/\/dx.doi.org\/10.3109\/03639045.2012.707209]. [PMID: 22817837].","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=385","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s12272-001-2161-7","volume":"31","author":"Choi J-S.","year":"2008","unstructured":"Choi J-S, Kang KW. Arch Pharm Res, Enhanced tamoxifen bioavailability after oral administration of tamoxifen in rats pretreated with naringin.,, 2008, 31,, 1631-1636,[http:\/\/dx.doi.org\/10.1007\/s12272-001-2161-7]. [PMID: 19099234].","journal-title":"Arch Pharm Res"},{"key":"ref=386","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ptr.1937","volume":"20","author":"Pattanaik S.","year":"2006","unstructured":"Pattanaik S, Hota D, Prabhakar S, Kharbanda P, Pandhi P. Phytother Res, Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy.,, 2006, 20,, 683-686,[http:\/\/dx.doi.org\/10.1002\/ptr.1937]. [PMID: 16767797].","journal-title":"Phytother Res"},{"key":"ref=387","first-page":"126","volume":"36","author":"Fuhr U.","year":"1998","unstructured":"Fuhr U, Maier-Br\u00fcggemann A, Blume H. Int J Clin Pharmacol Ther, Grapefruit juice increases oral nimodipine bioavailability.,, 1998, 36,, 126-132,[PMID: 9562227].","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref=388","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/jn\/134.8.1948","volume":"134","author":"Lambert J.D.","year":"2004","unstructured":"Lambert JD, Hong J, Kim DH, Mishin VM, Yang CS. J Nutr, Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice.,, 2004, 134,, 1948-1952,[http:\/\/dx.doi.org\/10.1093\/jn\/134.8.1948]. [PMID: 15284381].","journal-title":"J Nutr"},{"key":"ref=389","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3109\/03639045.2012.693502","volume":"39","author":"Challa V.R.","year":"2013","unstructured":"Challa VR, Babu PR, Challa SR, Johnson B, Maheswari C. Drug Dev Ind Pharm, Pharmacokinetic interaction study between quercetin and valsartan in rats and  models.,, 2013, 39,, 865-872,[http:\/\/dx.doi.org\/10.3109\/03639045.2012.693502]. [PMID: 22670860].","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=390","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s12272-012-1017-7","volume":"35","author":"Lee J.H.","year":"2012","unstructured":"Lee JH, Shin Y-J, Oh J-H, Lee Y-J. Arch Pharm Res, Pharmacokinetic interactions of clopidogrel with quercetin, telmisartan, and cyclosporine A in rats and dogs.,, 2012, 35,, 1831-1837,[http:\/\/dx.doi.org\/10.1007\/s12272-012-1017-7]. [PMID: 23139136].","journal-title":"Arch Pharm Res"},{"key":"ref=391","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1055\/s-0032-1314849","volume":"62","author":"Sama V.","year":"2012","unstructured":"Sama V, Nadipelli M, Yenumula P, Bommineni MR, Mullangi R. Arzneimittelforschung, Effect of piperine on antihyperglycemic activity and pharmacokinetic profile of nateglinide.,, 2012, 62,, 384-388,[http:\/\/dx.doi.org\/10.1055\/s-0032-1314849]. [PMID: 22753154].","journal-title":"Arzneimittelforschung"},{"key":"ref=392","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1055\/s-0031-1296235","volume":"61","author":"Venkatesh S.","year":"2011","unstructured":"Venkatesh S, Durga KD, Padmavathi Y, Reddy BM, Mullangi R. Arzneimittelforschung, Influence of piperine on ibuprofen induced antinociception and its pharmacokinetics.,, 2011, 61,, 506-509,[http:\/\/dx.doi.org\/10.1055\/s-0031-1296235]. [PMID: 22029226].","journal-title":"Arzneimittelforschung"},{"key":"ref=393","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/mnfr.201100117","volume":"55","author":"Johnson J.J.","year":"2011","unstructured":"Johnson JJ, Nihal M, Siddiqui IA. Mol Nutr Food Res, Enhancing the bioavailability of resveratrol by combining it with piperine.,, 2011, 55,, 1169-1176,[http:\/\/dx.doi.org\/10.1002\/mnfr.201100117]. [PMID: 21714124].","journal-title":"Mol Nutr Food Res"},{"key":"ref=394","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12272-011-0411-x","volume":"34","author":"Choi J-S.","year":"2011","unstructured":"Choi J-S, Piao Y-J, Kang KW. Arch Pharm Res, Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.,, 2011, 34,, 607-613,[http:\/\/dx.doi.org\/10.1007\/s12272-011-0411-x]. [PMID: 21544726].","journal-title":"Arch Pharm Res"},{"key":"ref=395","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4142\/jvs.2005.6.3.197","volume":"6","author":"Singh M.","year":"2005","unstructured":"Singh M, Varshneya C, Telang RS, Srivastava AK. J Vet Sci, Alteration of pharmacokinetics of oxytetracycline following oral administration of Piper longum in hens.,, 2005, 6,, 197-200,[http:\/\/dx.doi.org\/10.4142\/jvs.2005.6.3.197]. [PMID: 16131821].","journal-title":"J Vet Sci"},{"key":"ref=396","first-page":"1302","volume":"80","author":"Balakrishnan V.","year":"2001","unstructured":"Balakrishnan V, Varma S, Chatterji D. Curr Sci, Piperine augments transcription inhibitory activity of rifampicin by severalfold in ,, 2001, 80,, 1302-1305,","journal-title":"Curr Sci"},{"key":"ref=397","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bcp.2007.12.001","volume":"75","author":"Robey R.W.","year":"2008","unstructured":"Robey RW, Shukla S, Finley EM. Biochem Pharmacol, Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)).,, 2008, 75,, 1302-1312,[http:\/\/dx.doi.org\/10.1016\/j.bcp.2007.12.001]. [PMID: 18234154].","journal-title":"Biochem Pharmacol"},{"key":"ref=398","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0010-7824(95)00252-9","volume":"53","author":"Weber A.","year":"1996","unstructured":"Weber A, J\u00e4ger R, B\u00f6rner A. Contraception, Can grapefruit juice influence ethinylestradiol bioavailability?,, 1996, 53,, 41-47,[http:\/\/dx.doi.org\/10.1016\/0010-7824(95)00252-9]. [PMID: 8631189].","journal-title":"Contraception"},{"key":"ref=399","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/clpt.1993.84","volume":"53","author":"Bailey D.G.","year":"1993","unstructured":"Bailey DG, Arnold JMO, Munoz C, Spence JD. Clin Pharmacol Ther, Grapefruit juice--felodipine interaction: mechanism, predictability, and effect of naringin.,, 1993, 53,, 637-642,[http:\/\/dx.doi.org\/10.1038\/clpt.1993.84]. [PMID: 8513655].","journal-title":"Clin Pharmacol Ther"},{"key":"ref=400","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1006\/phrs.1999.0640","volume":"41","author":"Gupta S.K.","year":"2000","unstructured":"Gupta SK, Bansal P, Bhardwaj RK, Velpandian T. Pharmacol Res, Comparative anti-nociceptive, anti-inflammatory and toxicity profile of nimesulide  nimesulide and piperine combination.,, 2000, 41,, 657-662,[http:\/\/dx.doi.org\/10.1006\/phrs.1999.0640]. [PMID: 10816335].","journal-title":"Pharmacol Res"},{"key":"ref=401","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.2042-7158.2011.01434.x","volume":"64","author":"Lassoued M.A.","year":"2012","unstructured":"Lassoued MA, Sfar S, Bouraoui A, Khemiss F. J Pharm Pharmacol, Absorption enhancement studies of clopidogrel hydrogen sulphate in rat everted gut sacs.,, 2012, 64,, 541-552,[http:\/\/dx.doi.org\/10.1111\/j.2042-7158.2011.01434.x]. [PMID: 22420660].","journal-title":"J Pharm Pharmacol"},{"key":"ref=402","first-page":"1411","volume":"29","author":"Li X.","year":"2009","unstructured":"Li X, Choi J-S. Anticancer Res, Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.,, 2009, 29,, 1411-1415,[PMID: 19414395].","journal-title":"Anticancer Res"},{"key":"ref=403","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1358\/mf.2010.32.4.1452090","volume":"32","author":"Sharma V.","year":"2010","unstructured":"Sharma V, Nehru B, Munshi A, Jyothy A. Methods Find Exp Clin Pharmacol, Antioxidant potential of curcumin against oxidative insult induced by pentylenetetrazol in epileptic rats.,, 2010, 32,, 227-232,[http:\/\/dx.doi.org\/10.1358\/mf.2010.32.4.1452090]. [PMID: 20508869].","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"ref=404","first-page":"254","volume":"30","author":"Karan R.","year":"1998","unstructured":"Karan R, Bhargava V, Garg S. Indian J Pharmacol, Effect of trikatu (piperine) on the pharmacokinetic profile of isoniazid in rabbits.,, 1998, 30,, 254-,","journal-title":"Indian J Pharmacol"},{"key":"ref=405","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF02977476","volume":"29","author":"Yeum C-H.","year":"2006","unstructured":"Yeum C-H, Choi J-S. Arch Pharm Res, Effect of naringin pretreatment on bioavailability of verapamil in rabbits.,, 2006, 29,, 102-107,[http:\/\/dx.doi.org\/10.1007\/BF02977476]. [PMID: 16491851].","journal-title":"Arch Pharm Res"},{"key":"ref=406","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4142\/jvs.2008.9.1.25","volume":"9","author":"Dama M.S.","year":"2008","unstructured":"Dama MS, Varshneya C, Dardi MS, Katoch VC. J Vet Sci, Effect of trikatu pretreatment on the pharmacokinetics of pefloxacin administered orally in mountain Gaddi goats.,, 2008, 9,, 25-29,[http:\/\/dx.doi.org\/10.4142\/jvs.2008.9.1.25]. [PMID: 18296885].","journal-title":"J Vet Sci"},{"key":"ref=407","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4314\/ajtcam.v5i3.31281","volume":"5","author":"Janakiraman K.","year":"2008","unstructured":"Janakiraman K, Manavalan R. Afr J Tradit Complement Altern Med, Studies on effect of piperine on oral bioavailability of ampicillin and norfloxacin.,, 2008, 5,, 257-262,[http:\/\/dx.doi.org\/10.4314\/ajtcam.v5i3.31281]. [PMID: 20161946].","journal-title":"Afr J Tradit Complement Altern Med"},{"key":"ref=408","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.lfs.2008.06.007","volume":"83","author":"Bansal T.","year":"2008","unstructured":"Bansal T, Awasthi A, Jaggi M, Khar RK, Talegaonkar S. Life Sci, Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: possible contribution of P-glycoprotein.,, 2008, 83,, 250-259,[http:\/\/dx.doi.org\/10.1016\/j.lfs.2008.06.007]. [PMID: 18619980].","journal-title":"Life Sci"},{"key":"ref=409","first-page":"273","volume":"1","author":"Amar S.","year":"2010","unstructured":"Amar S, Pawar VK, Vikash J, Parabia MH, Rajendra A, Gaurav S. Res J Pharm Biol Chem Sci, \n                         assessment of enhanced bioavailability of metronidazole with piperine in rabbits.,, 2010, 1,, 273-278,","journal-title":"Res J Pharm Biol Chem Sci"},{"key":"ref=410","first-page":"486","volume":"28","author":"Mujumdar A.M.","year":"1990","unstructured":"Mujumdar AM, Dhuley JN, Deshmukh VK, Raman PH, Thorat SL, Naik SR. Indian J Exp Biol, Effect of piperine on pentobarbitone induced hypnosis in rats.,, 1990, 28,, 486-487,[PMID: 2401524].","journal-title":"Indian J Exp Biol"},{"key":"ref=411","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.bbrc.2008.08.054","volume":"375","author":"Einbond L.S.","year":"2008","unstructured":"Einbond LS, Shimizu M, Ma H. Biochem Biophys Res Commun, Actein inhibits the Na+-K+-ATPase and enhances the growth inhibitory effect of digitoxin on human breast cancer cells.,, 2008, 375,, 608-613,[http:\/\/dx.doi.org\/10.1016\/j.bbrc.2008.08.054]. [PMID: 18755149].","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=412","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jep.2011.10.001","volume":"139","author":"Liang X-L.","year":"2012","unstructured":"Liang X-L, Liao Z-G, Zhu J-Y. J Ethnopharmacol, The absorption characterization effects and mechanism of Radix Angelicae dahuricae extracts on baicalin in Radix Scutellariae using  and  absorption models.,, 2012, 139,, 52-57,[http:\/\/dx.doi.org\/10.1016\/j.jep.2011.10.001]. [PMID: 22023882].","journal-title":"J Ethnopharmacol"},{"key":"ref=413","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1021\/pr9005074","volume":"8","author":"Xu Y.","year":"2009","unstructured":"Xu Y, Wang Y, Yan L. J Proteome Res, Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant : endogenous ROS augmentation.,, 2009, 8,, 5296-5304,[http:\/\/dx.doi.org\/10.1021\/pr9005074]. [PMID: 19754040].","journal-title":"J Proteome Res"},{"key":"ref=414","first-page":"186","volume":"1","author":"Sun J.","year":"2011","unstructured":"Sun J, Liu B-r, Wei J. Biomedicine , The extract of Paris polyphylla exerts apoptotic induction and synergic antiproliferative effect with anticancer drugs in SMMC-7721 human liver cancer cells.,, 2011, 1,, 186-194,[http:\/\/dx.doi.org\/10.1016\/j.bionut.2011.06.019].","journal-title":"Biomedicine"},{"key":"ref=415","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2008.05.002","volume":"80","author":"Chuanasa T.","year":"2008","unstructured":"Chuanasa T, Phromjai J, Lipipun V. Antiviral Res, Anti-herpes simplex virus (HSV-1) activity of oxyresveratrol derived from Thai medicinal plant: mechanism of action and therapeutic efficacy on cutaneous HSV-1 infection in mice.,, 2008, 80,, 62-70,[http:\/\/dx.doi.org\/10.1016\/j.antiviral.2008.05.002]. [PMID: 18565600].","journal-title":"Antiviral Res"},{"key":"ref=416","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbrc.2008.10.169","volume":"378","author":"Liu J.","year":"2009","unstructured":"Liu J, He C, Zhou K, Wang J, Kang JX. Biochem Biophys Res Commun, Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cells.,, 2009, 378,, 174-178,[http:\/\/dx.doi.org\/10.1016\/j.bbrc.2008.10.169]. [PMID: 19000652].","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=417","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.fitote.2010.06.028","volume":"81","author":"Chen Z.P.","year":"2010","unstructured":"Chen ZP, Sun J, Chen HX. Fitoterapia, Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of  extracts,  extract phospholipid complexes and  extract solid dispersions in rats.,, 2010, 81,, 1045-1052,[http:\/\/dx.doi.org\/10.1016\/j.fitote.2010.06.028]. [PMID: 20603197].","journal-title":"Fitoterapia"},{"key":"ref=418","first-page":"677","volume":"5","author":"Kuamwat R.S.","year":"2012","unstructured":"Kuamwat RS, Mruthunjaya K, Gupta MK. Res J Pharm Technol, Hepatoprotective effect of Gallic acid and Gallic acid Phytosome against Carbon Tetrachloride induced damage in albino rats.,, 2012, 5,, 677-,","journal-title":"Res J Pharm Technol"},{"key":"ref=419","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/156720112800389070","volume":"9","author":"Singh D.","year":"2012","unstructured":"Singh D, Rawat MS, Semalty A, Semalty M. Curr Drug Deliv, Rutin-phospholipid complex: an innovative technique in novel drug delivery system- NDDS.,, 2012, 9,, 305-314,[http:\/\/dx.doi.org\/10.2174\/156720112800389070]. [PMID: 22283645].","journal-title":"Curr Drug Deliv"},{"key":"ref=420","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.dit.2013.02.004","volume":"5","author":"Habbu P.","year":"2013","unstructured":"Habbu P, Madagundi S, Kulkarni R, Jadav S, Vanakudri R, Kulkarni V. Drug Invent Today, Preparation and evaluation of Bacopa\u2013phospholipid complex for antiamnesic activity in rodents.,, 2013, 5,, 13-21,[http:\/\/dx.doi.org\/10.1016\/j.dit.2013.02.004].","journal-title":"Drug Invent Today"},{"key":"ref=421","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijpharm.2013.03.021","volume":"448","author":"Zhang J.","year":"2013","unstructured":"Zhang J, Tang Q, Xu X, Li N. Int J Pharm, Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery.,, 2013, 448,, 168-174,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2013.03.021]. [PMID: 23524117].","journal-title":"Int J Pharm"},{"key":"ref=422","first-page":"9","volume":"41","author":"Bhattacharya S.","year":"2009","unstructured":"Bhattacharya S. Pharm Times, Phytosomes: emerging strategy in delivery of herbal drugs and nutraceuticals.,, 2009, 41,, 9-12,","journal-title":"Pharm Times"},{"key":"ref=423","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2006.09.025","volume":"330","author":"Maiti K.","year":"2007","unstructured":"Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Int J Pharm, Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats.,, 2007, 330,, 155-163,[http:\/\/dx.doi.org\/10.1016\/j.ijpharm.2006.09.025]. [PMID: 17112692].","journal-title":"Int J Pharm"},{"key":"ref=424","first-page":"84","volume":"4","author":"Maiti K.","year":"2005","unstructured":"Maiti K, Mukherjee K, Gantait A, Nazeer Ahamed H, Saha BP, Kumar Mukherjee P. Ir J Pharmacol Therap, Enhanced therapeutic benefit of quercetinphospholipid complex in carbon tetrachloride-induced acute liver injury in rats: a comparative study.,, 2005, 4,, 84-0,","journal-title":"Ir J Pharmacol Therap"},{"key":"ref=425","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1211\/jpp.58.9.0009","volume":"58","author":"Maiti K.","year":"2006","unstructured":"Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. J Pharm Pharmacol, Enhanced therapeutic potential of naringenin-phospholipid complex in rats.,, 2006, 58,, 1227-1233,[http:\/\/dx.doi.org\/10.1211\/jpp.58.9.0009]. [PMID: 16945181].","journal-title":"J Pharm Pharmacol"},{"key":"ref=426","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejps.2013.06.012","volume":"50","author":"Elmowafy M.","year":"2013","unstructured":"Elmowafy M, Viitala T, Ibrahim HM. Eur J Pharm Sci, Silymarin loaded liposomes for hepatic targeting:  evaluation and HepG2 drug uptake.,, 2013, 50,, 161-171,[http:\/\/dx.doi.org\/10.1016\/j.ejps.2013.06.012]. [PMID: 23851081].","journal-title":"Eur J Pharm Sci"},{"key":"ref=427","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fitote.2013.07.025","volume":"91","author":"Einbond L.S.","year":"2013","unstructured":"Einbond LS, Mighty J, Redenti S, Wu HA. Fitoterapia, Actein induces calcium release in human breast cancer cells.,, 2013, 91,, 28-38,[http:\/\/dx.doi.org\/10.1016\/j.fitote.2013.07.025]. [PMID: 23939423].","journal-title":"Fitoterapia"},{"key":"ref=428","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.foodres.2013.04.004","volume":"53","author":"Zheng F-Y.","year":"2013","unstructured":"Zheng F-Y, Chen L-H, Li S-X, Qiu Y-Q. Food Res Int, Effect of edible plants combination on mineral bioaccessibility and bioavailability, using  digestion and liposome-affinity extraction.,, 2013, 53,, 174-179,[http:\/\/dx.doi.org\/10.1016\/j.foodres.2013.04.004].","journal-title":"Food Res Int"},{"key":"ref=429","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2016.09.017","volume":"241","author":"Alexander A.","year":"2016","unstructured":"Alexander A. J Control Release, Ajazuddin, Patel RJ, Saraf S, Saraf S. Recent expansion of pharmaceutical nanotechnologies and targeting strategies in the field of phytopharmaceuticals for the delivery of herbal extracts and bioactives.,, 2016, 241,, 110-124,[http:\/\/dx.doi.org\/10.1016\/j.jconrel.2016.09.017]. [PMID: 27663228].","journal-title":"J Control Release"},{"key":"ref=430","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.colsurfb.2005.12.011","volume":"48","author":"You J.","year":"2006","unstructured":"You J, Cui FD, Han X. Colloids Surf B Biointerfaces, Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.,, 2006, 48,, 35-41,[http:\/\/dx.doi.org\/10.1016\/j.colsurfb.2005.12.011]. [PMID: 16480856].","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=431","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/CAD.0b013e328332a322","volume":"21","author":"Chao P.","year":"2010","unstructured":"Chao P, Deshmukh M, Kutscher HL. Anticancer Drugs, Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model.,, 2010, 21,, 65-76,[http:\/\/dx.doi.org\/10.1097\/CAD.0b013e328332a322]. [PMID: 19966540].","journal-title":"Anticancer Drugs"},{"key":"ref=432","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.foodres.2012.04.023","volume":"48","author":"Nesterenko A.","year":"2012","unstructured":"Nesterenko A, Alric I, Silvestre F, Durrieu V. Food Res Int, Influence of soy protein\u2019s structural modifications on their microencapsulation properties: \u03b1-Tocopherol microparticle preparation.,, 2012, 48,, 387-396,[http:\/\/dx.doi.org\/10.1016\/j.foodres.2012.04.023].","journal-title":"Food Res Int"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169466","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T01:46:21Z","timestamp":1569203181000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169466\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,9]]},"references-count":432,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,7,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612825666190130110653","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-12-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}